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ABSTRACT
The Role of the Cytosolic Chaperonin CCT in Folding β-Propeller Proteins
William Grant Ludlam
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy
Many Proteins require the aid of molecular chaperones to achieve a stable folding state and
avoid misfolding pathologies. A major eukaryotic chaperone is the cytosolic chaperonin CCT.
While CCT is known to fold a significant portion of all cytosolic proteins, there is no general
model for the mechanism CCT uses to fold substrate proteins. One class of proteins that CCT is
known to fold are β-propeller containing proteins. Here, we present structural and biochemical
data on the processes that CCT uses to fold three distinct β-propeller proteins: the G-protein Beta
5 (Gβ5) subunit of the Gβ5-RGS complex, mLST8 of the mTOR complexes, and BBS2, 7, and 9
of the BBSome. We also explore the mechanisms by which these proteins are assembled into their
respective signaling complexes after being folded by CCT. We found that each CCT substrate
follows a unique folding trajectory and posit that the major determinants underlying each trajectory
are governed by interactions between the substrate and CCT and interactions with downstream
binding partners.

Keywords: chaperones, CCT, G proteins, mTOR, BBSome, β-propeller, cryo-electron
microscopy
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Chapter 1 : Introduction
The protein folding problem
Proteins are primary building blocks in all human cells. Proteins do everything from
forming enzymes that breakdown the food we eat to giving structure to our skin and vital organs.
The fundamental components of proteins are amino acids. Ribosomes assemble amino acids into
long chains called nascent peptides by decoding mRNA. Before these string-like peptides can be
functional, they must first fold into specific and complex shapes. When proteins fail to fold
properly, they can be highly toxic for the cell. Many neurodegenerative diseases, such as

Figure 1-1 An energy folding landscape. Adapted from [1]

Alzheimer’s, Huntington’s and Creutzfeldt-Jakob disease are caused by build ups of proteins in
cytotoxic states [2]. Furthermore, when proteins fail to fold properly, they can no longer perform
1

their function in the cell. This can lead to birth defects, cancer, and cognitive and motor
impairment [2].
Protein folding is driven by intramolecular interactions. Each amino acid has specific
chemical properties and can form interactions with other amino acids and the surrounding
solvent [3]. Amino acids that are non-polar do not interact with water molecules in the solvent,
but rather bury themselves in the interior of the protein, away from the solvent interface. This
hydrophobic effect, together with Van der Waals interactions, is the major driving force behind
spontaneous protein folding [3, 4]. The intrinsic geometry in the bond angles formed between
amino acids causes them to form α-helices and β-pleated sheets. These helices and sheets pack
can pack around the hydrophobic core in variety of different conformations. Some conformations
lend themselves to greater stability by forming more intramolecular interactions [4].
Proper protein folding is difficult to achieve because nascent protein chains can adopt
such a wide range of conformations [4, 5]. In fact, until recently, predicting how a protein will
fold based on its amino acid sequence was nearly impossible, even for the most sophisticated
programs and computers [4]. After being synthesized by ribosomes, proteins explore a landscape
of potential conformations with different energies [5]. Conformations with greater stability are
represented by low points in the energy landscape, while less stable conformations are
represented by high points. The high points also form barriers between low points [5].
Sometimes, a protein can become stuck in a local energy minimum because they lack the energy
to pass over these barriers by adopting unstable conformations [5]. Most of these minima,
however, represent stable but non-functional folding states [5]. These states are generally toxic
for the cell.
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To aid proteins to pass over energy barriers and to avoid local minima, cells use the
assistance of other proteins called chaperones (Figure 1-1). Chaperones employ two main
strategies to help proteins reach their native fold. The first involves simply interacting with
proteins in nonfunctional states and destabilizing them so that they can attempt fold again
correctly [1]. By holding on to the proteins until it folds correctly, the chaperone can be said to
act as a holdase. This passive strategy keeps proteins out of toxic low energy minima. The
second strategy involves adding energy to the nascent peptide so that it can pass over an energy
barrier. This energy input is often in the form of the chaperone interacting with the molecule
adenosine triphosphate (ATP) [1]. ATP induces changes in the 3D shape or conformation of the
chaperone. Such changes can reduce the degrees of freedom that the nascent peptide substrate
can explore in its own conformational energy landscape [6]. In this more active capacity, the
chaperone can be said to act as a foldase.

The cytosolic chaperonin CCT
Eukaryotic cells contain hundreds of different chaperones in several classes. One specific
class of chaperones are called chaperonins. The primary chaperonin active in the eukaryotic
cytosol is the chaperonin-containing tailless complex polypeptide 1 (CCT) or alternatively called
the tailless complex polypeptide 1 ring complex (TRiC), where it is estimated to fold at least
10% of all newly synthesized protein [7]. CCT is formed of two identical rings of eight unique
subunits that form a barrel shape [8, 9]. (Figure 1-2) Nascent peptides can enter the cavity of the
barrel where they are protected from the outside cytosolic environment of the cell until they can
properly fold. Each subunit is composed of three separate domains: the equatorial, intermediate
and apical domains. The equatorial domains bind adenosine nucleotides and are located at the
3

interface between the two rings. A region known as the sensor or stem loop acts as the interface
between subunits. This β-hairpin structure projects negatively charged residues out into the
central cavity that can interact with partially folded substrates [10]. Additionally, the amino- (N-)
and carboxy- (C-) termini of each subunit form long unstructured strands that extend from the
equatorial domains into the central cavity, forming a loose barrier between the hemispheres
formed by the two rings of subunits [11]. The N- and C- termini interact with the stem-loop of
adjacent subunits [9, 10]. This interaction is believed to govern cooperativity between subunits.
By contrast, the apical domains form finger-like projections that extend out from the wall of the
barrel and point into the central cavity and form the outer rim of the barrel. On the apical
domains, substrates bind to regions known as the Release Loop of Substrate (RLS), the proximal
loop (PL), and α-helix 11 (H11) [1, 10-12]. Lastly, the intermediate domain creates a hinge
between the equatorial and apical domains and allow the two domains to communicate to each
other.
CCT subunits can bind and hydrolyze ATP to adenosine diphosphate (ADP) to induce
conformational changes in the barrel shaped structure of CCT. When ATP is hydrolyzed, it is
split into one molecule of ADP and one molecule of inorganic phosphate. When both ADP and
the inorganic phosphate are present in the nucleotide binding pocket of the equatorial domain,
the subunit changes conformation such that the apical domains lean into the central cavity and
form a barrier between the outside environment and the inner cavity [9]. Additionally, the
termini are believed to retract from inside the cavity and pack along the inside wall of the cavity
[9]. This conformational change is referred to as the transition state (Fig 1-2). When the CCT
cavity closes, the volume inside the barrel is dramatically reduced [13]. Closing the cavity traps
the substrate in a restricted space, reducing the conformational degrees of freedom available and
4

thereby directing the substrate towards a functional fold. Additionally, the rotation of each
subunit could expose new residues inside the cavity, breaking some interactions with substrate
and forming new connections [9, 12]. These changes could stabilize the substrate in specific
states along the folding trajectory. Apart from these hypotheses, it is still unknown exactly how
ATP aids in folding of substrates. Once the phosphate and/or ADP molecule diffuse out of the
nucleotide binding pocket, the conformational restraints imposed in the transition state are
relaxed and the CCT cavity reopens [14]. Eventually, the nucleotide is replaced with fresh ATP
and the hydrolysis cycle repeats.

Figure 1-2 The Chaperonin CCT A) ATP cycle of CCT; B) Annotated example CCT subunit. H11—Helix 11, PL—
proximal loop, RLS—Release loop of substrate; PDB: 6QB8; C) The sensor loop of one subunit makes a β-sheet with the
C-terminus of an adjacent subunit (gray); The lid segment makes contact with the RLS of an adjacent subunit

There is still debate as to whether the CCT subunits hydrolyze ATP and close in a
sequential or concerted manner or if they are each act independently to close. There have been
several CCT structures solved in different nucleotide states and with varying concentrations of
nucleotide present that have attempted to answer this question. An early study added increasing
amounts of ATP to CCT and looked at the conformational flexibility of the CCT apical domains.
They found that the flexibility decreased first in the CCT2 and CCT4 and then progressively
5

around each side of the CCT ring to the CCT6 and CCT8 subunits, which maintained flexibility
even at high ATP concentrations [15]. Later, similar experiments were performed using CCT
isolated from yeast in complex with ADP-AlFx, a nucleotide that mimics the transition state from
ATP to ADP plus inorganic phosphate [9, 11]. When no ADP-AlFx was added, there was still
residual ADP present in the CCT6 and CCT8 subunits, which are believed to not exchange ADP
for ATP at any appreciable rate [11]. This state was therefore termed the nucleotide partially
preloaded (NPP) state. The CCT2 subunits also adopted a characteristic Z-shape in the NPP state
[11]. At increasing concentrations of ADP-AlFx, CCT7 and then CCT2 shifted conformations,
even though all but CCT4 had nucleotide [9]. At higher ADP-AlFx concentrations, all the
subunits adopted a closed conformation. This suggested that CCT4 is a gatekeeper for CCT ring
closure; CCT cannot close completely unless CCT4 is occupied by nucleotide.
These structures provide mechanistic insight into what residues are involved in the
closure of the CCT cavity. In the closed state, K162 on the nucleotide-sensing loop (NSL) and
D398 on H11 of the intermediate domain are pulled in to interact with the nucleotide [9]. This
causes a rotation in the intermediate domain and apical domains. Meanwhile, D60 on the stemloop is also pulled in towards the nucleotide [9]. This alters the contacts with the neighboring Nand C- termini and is believed to drive intra- and inter- ring coordination for closure.

Evolutionary Development of Chaperonins
CCT is capable of folding some client substrates that its evolutionary predecessor, the
prokaryotic chaperonin GroEL, cannot [1]. Indeed, many the of most significant proteins folded
by CCT, such as the structural protein actin, cannot be folded by GroEL [1]. GroEL has seven
6

identical subunits as opposed to the eight unique subunits of CCT [14]. GroEL has a similar
barrel shape to CCT, but the inside cavity is largely hydrophobic in the inactive state (Fig 1-4).
This hydrophobic environment is believed to destabilize misfolded proteins and allow them to
refold, indicating GroEL acts as a nonspecific holdase [1]. Indeed, GroEL can bind and hold
some CCT substrates, such as actin, but is unable to help them achieve a native fold [1]. GroEL
also hydrolyzes ATP, which allows a co-chaperonin called GroES to bind on top of the cavity in
a manner analogous to the closing of the cavity by the CCT apical domains [1, 14]. Closure of
the cavity causes rotation of the GroEL subunits that expose polar residues [16]. This mimics the
polar nature of the cytosol, allowing the protein to fold while still being shielded from
interference from the outside environment. There is no evidence, however, that ATP hydrolysis
directly induces specific conformational changes in GroEL substrates. By contrast, the
environment inside the cavity of CCT contains a mixture of polar and hydrophobic areas [8, 12,
17]. The specific ordering of the subunits creates distinct areas inside the CCT cavity. On one
side, the CCT1, 3, 6, and 8 subunits are more positively charged and have lower affinity for ATP
while CCT4, 2, 5, and 7 are negatively charged and have higher affinity for ATP (Figure 1-3A)
[12, 17, 18]. Likewise, the CCT3, 6, and 8 subunits have a very slow hydrolysis rate and have the
least conserved sequence identity (Figure 1-3B, C) [8]. This partitioning has led to the “power
stroke” hypothesis that nascent proteins first bind the fast hydrolyzing side of the cavity and are
then passed to the slow hydrolyzing side where they wait until they finish folding [18]. The H11
and PL regions of the apical domains of each CCT subunit also contain a unique “barcode” of
charged, polar, and hydrophobic residues. These barcodes have been predicted to act as sequence
recognition sites and allow CCT to specifically bind to a large array of client proteins [12].

7

Figure 1-3 Functional partitioning of CCT hemispheres.. A) View of positive patch inside CCT cavity. Residues
are labeled positive—blue, negative—red, PDB:6KS6. B) Relative ATP hydrolysis potencies of each CCT subunit.
Thicker sections symbolize greater ATP hydrolysis rates. C.) Sequence similarity of each CCT subunit to consensus
sequence. Adapted from [8]

While no consensus sequence of CCT
substrates has been discovered, one large class of
substrates are β-propeller containing proteins [14,
19]. β-propellers are circular structures formed
typically from seven β-sheets that contain a
repeating tryptophan-aspartate (WD) motif every 40
amino acids (Fig 1-4). The first strand on the amino
Figure 1-4 An example β-propeller. Red—Nterminal β-strand; yellow—C-terminal βstrand; PDB: 1A0R

side of the propeller completes the β-propeller ring
by binding to the final β-sheet on the carboxy side

of the protein. Many β-propeller proteins have been shown to bind CCT after the 4th or 5th βsheet has been synthesized by the ribosome [19]. CCT has been predicted to stabilize the nearly
completed β-propeller until the amino- and carboxy- sides can meet up to form the complete ring
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[19]. This interaction indicates that CCT acts co-translationally with the ribosome to begin
folding proteins before they are finished being synthesized.

CCT co-chaperones
Just as GroEL works with GroES to fold proteins, CCT also has auxiliary proteins or cochaperones that assist in the folding of specific protein substrates. One such co-chaperone is
prefoldin (PFD). PFD is composed of six distinct subunits that bind to an electrostatic interface
at the rim of the CCT barrel (Figure 1-5) [17]. PFD is believed to stabilize unfolded substrates
until they can bind CCT and finish folding. PFD pivots on this interface between a “latched” and
“engaged” state, where it serves as an extension of the electrostatic surface inside the CCT cavity
[17]. PFD has also been shown to increase the rate of folding of substrates when bound to CCT,
likely by improving the efficiency of each folding cycle [17].

Figure 1-5 CCT co-chaperones. A) Prefoldin bound on CCT. B) Structure of Prefoldin. PDB: 6NR9. C) PhLP1
bound to CCT. D) Structure of PhLP1.

9

A second family of CCT co-chaperones are the Phosducin-like Proteins (PhLP). The
manner that PhLPs contribute to folding still remains poorly understood. The isoform PhLP1 has
been observed to bind at the rim of the CCT cavity [20]. Depending on the substrate, PhLP1 can
stabilize the substrate on CCT or stabilize it after it has been released from CCT [21, 22]. To be
active in folding, PhPL1 is phosphorylated by casein kinase on three sequential serines (S18-20)
near its N-terminus [23, 24]. These residues form a large negative patch that can interact with a
positive patch on CCT6 [23]. PhLP2 is involved in CCT-mediated actin folding [13, 25].
Additionally, the isoform PhLP3 has been shown to decrease the rate of ATP hydrolysis on CCT
[26, 27].

Canonical CCT Folding Mechanism: Actin
The most common CCT substrates are the structural proteins actin and tubulin [6]. While
the CCT folding mechanism for most proteins remain unknown, there has been significant
research into the mechanism of folding of actin. The monomeric form of actin (G-actin) is
composed of two lobes. ATP and Mg2+ bind in between the two lobes and bring them together.
Actin has been observed to bind initially at the groove formed between the PL and H11 of CCT
[1]. Upon cavity closure, the RLS of an adjacent subunit rotates and brushes against the PL-H11
interface, displacing the actin. Specifically, actin binds at the apical domains of the fast ATP
hydrolyzing CCT4, 2, and 5, subunits. Once CCT binds to ATP, actin is released from fast
hydrolyzing CCT2 and 5 and binds to the slow hydrolyzing CCT7 and 8. At this point, the two
lobes fold independently, but bind on opposite sides of the CCT cavity, leaving the G-actin ATP
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binding pocket open to take up nucleotide. Once G-actin binds nucleotide, the two lobes come
together and the actin is released from CCT in a native state [1].

Figure 1-6 The sequential folding of actin. Adapted from [1]. PDB:2BTF

The tailored, stepwise folding mechanism of actin, together with the fact that noneukaryotic chaperonins are incapable of folding actin, suggest that actin was able to develop its
complex folding topology in a co-evolutionary manner with CCT. This raises the question of
whether all CCT substrates have a unique folding trajectory or whether a more general folding
mechanism exists. Of specific interest are questions such as how does CCT interact with proteins
containing β-propellers to help them achieve a native fold, what role does ATP play in βpropeller folding and what auxiliary proteins are involved? To answer these questions, we will
examine the folding mechanisms of β-propellers from a variety of cellular systems including: Gprotein signaling complexes, the mTOR signaling complexes, and the Bardet-Biedl Syndrome
protein trafficking complex (BBSome).

G-protein Signaling Complexes
The single largest class of signaling molecules in eukaryotes are G-protein Coupled
Receptors (GPCR) and their associated G proteins. About one third of all Food and Drug
11

Administration (FDA) approved drugs target G-protein signaling [28]. G-proteins respond to a
wide array of signals, including hormones, neurotransmitters, and even photons of light. When
an extracellular signal reaches a cell, it can be detected by a G-protein coupled receptor. GPCRs
are composed of a seven transmembrane helical bundle. The signal interacts with extracellular
portion of the GPCR, triggering conformational changes in the helical bundle on the intracellular
side of the receptor. G-proteins interact with GPCRs on this intracellular surface. When the
GPCR is activated, the G-proteins are released from the receptor and are free to diffuse along the
plasma membrane, where they interact with their downstream effectors (Fig 1-7) [29]. This
interaction causes an amplifying signaling cascade and allows G-proteins to affect large changes
inside the cell in response to very small stimuli.
G-proteins are composed of three different subunits named Gα, Gβ, and Gγ. The Gα
subunit is composed of two domains that are linked by a molecule of guanidine diphosphate
(GDP). In the GDP state, Gβ and Gγ bind to Gα. At this point, the Gαβγ heterotrimer can bind to
an activated GPCR receptor. The receptor induces changes in Gα that allow it to hinge open the
two domains to exchange GDP for a new GTP. Once in the GTP bound state, Gα releases from
the receptor and Gβ and Gγ. Gα downstream effectors include adenylyl cyclase (AC) (which
produces cyclic adenosine monophosphate (cAMP)), phosphodiesterase, phospholipase C (PLC),
and RhoA. Over time, the Gα subunit hydrolyzes the GTP to guanidine diphosphate (GDP).
When this happens Gα is prevented from binding to downstream effectors. The Gαβγ
heterotrimer must reform and bind to an activated receptor to receive fresh GTP and the cycle
repeats.
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While there are
over 800 unique
GPCRs, there are only
a handful of unique G
proteins. There are 16
variants of the Gα
subunit, which can be
broken into four main
families. The Gαs
family activates AC,
while the Gαi/o family

Figure 1-7 The G protein cycle.

inactivates AC and activate phosphodiesterase. The Gαq/11 family activates phospholipase C and
Rho and Gα12/13 also activates Rho. Gβ subunits are can be broken into two main families. Gβ1–
4 bind to Gγ, while Gβ5 binds to members of the Regulator of G-protein Signaling family [29].
Gβγ effectors include calcium channels, PLC and Ras.
Gβ and Gγ are obligate dimers, which means that they are not stable unless they are
bound to each other. Gβ is composed of one β-propeller with a single α-helix extending from its
N-terminus. Gγ is mainly α-helical in nature and interacts with the α-helix on Gβ to form a
coiled-coil interaction. Gβγ interacts with its downstream effectors on the same surface where
Gβ binds to Gα. Thus, Gα is an inhibitor of Gβγ signaling.
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Figure 1-8 Folding trajectories of Gβ subunits. A) Folding trajectory of Gβ1. B) Folding trajectory of Gβ5.Adapted
from [22]. C) Model of binding of Gβ1 and PhLP1 to CCT.

On its own, Gα hydrolyzes GTP too slowly to match the rapid rates of many G proteinmediated physiological responses. A special class of proteins called Regulators of G-protein
Signaling (RGS) proteins aid Gα subunits to hydrolyze GTP faster. In the nervous system and
retina, RGS proteins interact with a special variant of Gβ called Gβ5 to help bind Gα. While Gβ
variants 1–4 are all highly conserved, Gβ5 differs from the rest of the Gβ family. RGS proteins
contain a Gγ-like α-helical domain that interacts with the Gβ α-helix in the same manner as Gγ.
As obligate dimers, Gβγ and Gβ5-RGS rely on chaperones to maintain stability until they
can bind to each other. CCT and the co-chaperone PhLP1 help in the folding of Gβ proteins. In
fact, Gβ proteins are among the most common types of PhLP1 substrates [30]. PhLP1, however,
plays slightly different roles for the different variants of Gβ [22]. In the case of Gβ1, knockout of
PhLP1 increases the affinity of Gβ1 for CCT [22, 23]. Gβ1 can also bind PhLP1 independent of
CCT [24]. This suggests that PhLP1 releases Gβ1 from CCT and stabilizes it until it can bind to
Gγ. By contrast, PhLP1 expression increases the binding of Gβ5 to CCT, suggesting that it either

14

delivers Gβ5 to CCT or that it stabilizes Gβ5 on CCT until an RGS protein can bind and release
Gβ5 [22].
Structural studies indicate that Gβ1 binds at the rim of the cavity of CCT on the slow
ATP-hydrolyzing CCT3 and CCT6 subunits [20]. The main point of interaction between Gβ1
and CCT is through the Gγ-binding α-helix on Gβ1 [20]. PhLP1 bridges the top of the CCT
cavity and interacts directly with Gβ1, presumably preparing it for release [20]. These previous
structural studies were of low resolution. Improvements in electron microscopy technology now
allow for visualization of large protein complexes at near-atomic resolution. New and additional
studies of CCT folding Gβ proteins will elucidate the mechanism by which CCT folds this
important class of CCT substrates. Furthermore, it remains unknown how CCT folds Gβ5.
Because of the different role of PhLP1 in Gβ5 folding, it is possible that CCT also interacts with
Gβ5 in a manner distinct from Gβ1. In chapter 2, we present a structural model of CCT and
PhLP1 folding Gβ5 and discuss the differences in the folding mechanism of Gβ1.

The mTOR signaling complexes
There are many β-propeller proteins outside of the Gβ family, and we wanted to know if
these proteins were folded in a manner similar to Gβ1, or if they had distinct folding
mechanisms. To address this question, we investigated two β-propeller proteins that were folded
by CCT in the mTORC signaling complexes called Raptor and mLST8 (also known as Gβ-like
protein) [31]. The mechanistic Target of Rapamyacin (mTOR) kinase is a master regulator of
cell growth and metabolism [32, 33]. The kinase participates in two functionally distinct
complexes: the mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) [32, 33]. These
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complexes respond to a variety of inputs such as nutrients and hormones like insulin [33]. In
response, the mTOR complexes phosphorylate a wide variety of proteins that control protein,
nucleic acid and lipid synthesis as well as cell proliferaction [33]. By activating these pathways,
mTOR presents a major drug target for cancer and diabetes therapies as dysfunctional mTOR
activity leads to these diseases [32, 33].
The functional differences between the mTORC1 and mTORC2 complexes come from
their differing subunit compositions. The mTORC1 subunits include the mTOR kinase,
mammalian lethal with Sec13 protein 8 (mLST8), and regulatory associated protein of mTOR
(Raptor). mLST8 is a regulatory protein that stabilizes the kinase domain of mTOR. It is
composed of a single β-propeller [34]. Raptor contains domains for binding to mTORC1
substrates and also contains a C-terminal β-propeller [34]. mTORC1 substrates include
translational regulators and ribosome biogenesis proteins 4EBP and S6 kinase. It also inhibits
apoptosis by targeting Bcl-2 and represses autophagy by phosphorylating ULK1[32, 33]. In the
case of mTORC2, the subunits include mTOR kinase, mLST8, rapamycin insensitive companion
of mTOR (Rictor) and mSIN1. mSIN1 and Rictor help target mTORC2 to phosphorylate targets
such as the insulin receptor IRS1, Protein Kinase B (Akt), Protein Kinase C, and Serum and
Glucocorticoid-regulated Kinase 1 (SGK1) [32, 33]. Notably, Rictor does not contain a βpropeller fold [35].
Recent structural work has elucidated the mechanism of mTORC1 kinase activity. The
mTOR kinase is composed of HEAT (Huntingtin, EF3A, ATM, TOR), tetratricopeptide (TPR)
repeats, a FAT (Frap, ATM, TRRAP), and a phosphatidylinositol-kinase–related kinase (PIKK)
domain [34]. The mTORC1 complex is activated when the membrane tethered small GTPase
RHEB-GTP binds in the middle of the HEAT domain [36]. This allosterically causes a bend in
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the FAT domain that creates a space for the N-terminal lobe of the kinase domain to fill [36].
The readjustment of the N-lobe brings the catalytic residues of the kinase domain into register
and allows for mTOR to phosphorylate substrates [36]. Additionally, mTOR binds to mLST8 as
an obligate dimer through its the LST8 binding element (LBE) region on the C-lobe of the kinase
domain. This binding pinches the active site closed and allows for mTOR kinase activity.
The mTORC1 complex also contains the regulatory Raptor subunit. Raptor recruits
substrates containing TOR signaling sequences (TOS) [36]. Raptor is itself regulated by the
Ragulator complex on the lysosome [37]. Nutrient levels in the lysosome determine the
nucleotide states of Rag subunits [37]. One specific combination (RagA/B•GTP–RagC/D•GDP)
allows Raptor to bind to the Ragulator complex [37]. This binding event tethers the mTORC1
complex to the lysosome membrane, where it can interact with RHEB-GTP [37]. Raptor contains
an N-terminal conserved (RNC) caspase-homology domain, an armadillo repeat domain (ARM),
and a C-terminal β-propeller domain [34]. TOS containing substrates bind between the RNC and
ARM domains [36].

Figure 1-9 mTOR complex and components. Structural models of A) mLST8. B) Raptor. C) mTOR kinase. D)
mTOR complex 1. Domains are annotated. PDB:6BCX.

The mechanism of activation of mTORC2 is less understood. It most likely involves the
buildup of phosphotidyl inositol (3,4,5) triphosphate at the plasma membrane [38]. This can
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either attract mSin1 to the membrane and/or induce conformational changes in mTOR when it is
brought to the membrane [38].
Before mTOR can be active, it must first be assembled into a complex. mTOR itself is
folded by the Hsp90 TTT-R2TP chaperone complexes [39]. It remains unknown how the other
subunits are assembled together into a complex once they are folded by their chaperones. In
chapter 3, we show that CCT plays an important role in folding the β-propeller containing
subunits mLST8 and Raptor and assisting in the assembly of mTOR complexes. Furthermore, we
present a structure of a folding intermediate of the CCT-mLST8 complex.

The Bardet-Biedl Syndrome protein trafficking system
The last system of proteins we examine are the Bardet-Biedl Syndrome associated
proteins of the BBSome. Bardet-Biedl syndrome (BBS) is a rare autosomal recessive and genetic
disorder with a wide variety of symptoms. Primary features of the disease include rod-cone
dystrophy, polydactyly (extra digits), obesity, learning disabilities, hypogonadism (in males), and
renal anomalies [40]. Other features include speech abnormalities, brachydactyly/syndactyly,
polydipsia/polyuria, ataxia, diabetes mellitus, hepatic fibrosis, developmental delay, left
ventricular hypertrophy/congenital heart disease, abnormal dentition/palatal defects, and
strabismus/cataracts/astigmatism [40]. The details of how these phenotypes are developed are
still unclear.
Genetic and pedigree analysis of individuals with BBS have identified over 20 genes that
are linked to the disease. The genes have been identified as encoding proteins present in the
primary cilia of cells. The primary cilium is an antennae-like structure that protrudes from the
18

cell body and is packed with signaling receptors on its surface. The cilium is a major hub of
communication between the rest of the body and the cell. Information passed through the cilia
can tell a cell to divide, what type of cell it should become, or what compounds the cell should
produce. The light sensing outer segments of photoreceptors in the retina are also modified cilia
[41]. Thus, many of the symptoms of BBS are related to ciliary malfunction. Signaling receptors
and other important ciliary proteins are trafficked into and out of the cilia using the Intraflagellar
Transport (ITF) system [42, 43]. Anterograde movement outward to the tip of the cilia is
mediated by kinesin motor proteins and retrograde movement away from the tip is mediated by
dynein motor proteins [43].
Eight of the BBS genes (BBS1, 2, 4, 5 ,7 ,8, 9, and 18) encode for a roughly 500 kDa
protein complex called the BBSome [44-46]. The BBSome is proposed to act as a scaffold
between cargo proteins and IFT proteins [43]. A small GTPase protein call ADP ribosylationlike protein 6 (ARL6, also BBS3) acts as a reversible connection between the BBSome and IFT
machinery[45-47]. In the GTP bound state, ARL6 binds to the ciliary membrane and tethers the
BBSome to the membrane so it can interact with IFT proteins and traffic proteins out of the cilia
(Figure 1-10A)[45-47]. Loss of BBSome function results in improper cilia morphology and
impaired ciliary signaling [49-51].
The BBSome traffics a large number of GPCR substrates in the cilia. These receptors
bind to the BBSome by their C-terminus [52] and third intracellular loop (ICL3) [52, 53]. They
include the serotonin receptor 6 (5-HT-6) [53], the somatostatin receptor 3 (SSTR3) [52, 53], the
melanin-concentrating hormone receptor 1 (MCHR-1) [53], and the Smo [54] and GPR161 [55]
members of the Hedgehog signaling pathway.
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Before the BBSome can function, it must first be assembled from its many individual
subunits (Figure 1-10B). These subunits themselves must first be folded before they are
assembled together. Four BBSome subunits (BBS1, 2, 7, and 9) contain β-propellers and at least
one, BBS7, has been shown to require CCT for folding [56]. Three additional proteins (BBS6,
10, and 12) are known as the chaperonin-like BBSome complex (BBS-CL). They bare structural
similarity to CCT and aid in the folding of BBS7 [57]. Until BBS7 can bind to BBS2 and 9, it is
unstable in the cell and is dependent on this network of chaperones for stability [57]. The core
BBS2-7-9 complex is the first known stable assembly intermediate of the BBSome [57].
An alternative core complex composed of BBS1, 4, 5, 8, 9, and 18 is also possible [45].
Because the analogues of BBS2 and BBS7 do not exist in drosophila, this alternative core
complex is the main core complex in this animal. Additionally, BBS2 and BBS7 are not
necessary for entry into mammalian photoreceptor cilia, while they are required for entry into the
primary cilia of other cells [41]. In humans, however, mutations in either BBS2 or BBS7 are
sufficient to cause BBS, indicating that BBS2 and BBS7 play a crucial role in forming the
complete BBSome and allowing it to be functional.
To better understand the role that CCT plays in this process, a stepwise series of
structures of each stage in the assembly of the complete BBSome will be highly advantageous.
The structures will indicate what interactions drive assembly of the complex and will also answer
the question of how mutations in individual subunits can disrupt the formation of the complex.
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We have investigated the structure of the BBS2-7-9 complex and present a model of the complex
in chapter 4.

Figure 1-10 BBSome Function and Assembly A) BBSome mediated ciliary transport. B) Sequential assembly of the
BBSome. Adapted from [48].

Methods for Structural Determination
To study these complexes at the molecular level, we employed a technique called cryoelectron microscopy (cryo-EM). This technique involves purifying a protein sample and applying
it to as small grid. The grid is then plunge frozen in liquid ethane to protect the sample. Because
most protein complexes are smaller than the wavelength of visible light, a beam of electrons is
used to image the sample. The beam is passed through the sample and scattered based on
interactions with the protein sample. The beam is then refocused into an image on a detector
using electromagnetic lenses. The resulting low-resolution image contains a field of protein
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particles in a variety of orientations. The individual particle images can then be isolated and
aligned to average out the noise and create a single clearer image. Images of particles in different
orientations can be arranged in 3-dimensional space to create an overall model of the protein
complex. These static reconstructions represent the average consensus shape of the complex.
Given the flexible and dynamic nature of the CCT apical domains and of the partially
folded substrates inside CCT, static reconstructions of the complex cannot convey adequate
information about the nature of the complex. To analyze how CCT-substrate complexes behave
in solution, we employed novel techniques to measure the conformational heterogeneity of
complex. There are multiple implementations of this new technology (Manifold Embedding, 3Dimensional Variability analysis (3DVA), multibody refinement, AlphaCryo4D). Here, we
describe the theory behind the 3DVA capability available in the Cryosparc software package.
Unlike in protein crystallography, particles in electron microscopy data are free to adopt a
large range of conformations. In a generic single particle analysis workflow, only a small subset
of particles in the same conformation are used for the final high-resolution reconstruction. If
particles with different conformations are included, then the flexible regions will appear as
missing or blurry in the final reconstruction. Thus, most of these particles are discarded during
image processing. With enough of these particles, however, it is possible to form multiple
distinct structures of the complex in different conformations. If the complex moves in a
continuous motion, then these discrete structures can be arranged like frames in a movie and the
changes in the protein can be observed at each step.
These particles can also be used to generate an energy landscape of the conformational
dynamics of the complex. Assuming the particles follow a Boltzmann distribution, the
probability of finding a particle in any particular conformation is a function of the energy of the
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particle in that state. Abundant particles in a given conformation can be assumed to be in a more
stable state than particles in less abundant conformations. This analysis can therefore be used to
measure the size of energy barriers between stable states.

Figure 1-11 Conceptual workflow of EM data processing. A) Single particle analysis. Image courtesy of Jorge
Cuellar, CNB, Madrid, Spain. B) Variability analysis.
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Practically, this analysis is performed by arranging each particle in a hyper-dimensional
space using some attribute of the particle, such as treating the intensity of each pixel as a value in
a different dimension (manifold embedding), by solving a 3D model omitting the given particle
(AlphaCryo4D), or based on variance from a provided base structure (3DVA) [58]. The
dimensionality of the hyper-space is then reduced using Principle Component Analysis (PCA) in
the case of 3DVA [58] and multibody refinement [59] or machine learning in the case of
AlphaCryo4D. The arbitrary number of reduced dimensions represent movement trajectories of
the protein. Particles can then be binned into clusters as the trajectory is transversed from one
end to the other. The particles in each cluster are then used to solve a different 3D reconstruction.
Notably, a single particle has a position along each of the trajectories and is therefore binned
differently in each trajectory.
We use this technique to look at the conformational changes in CCT and in bound
substrates. We demonstrate that a folding mutation of Gβ5 alters the energy landscape of the
substrate and interferes with CCT-mediated folding. We also provide continuous electron
densities of CCT in states that have been inferred, but not directly observed until this point.
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Abstract
To perform their physiological functions, nascent G protein β subunits (Gβ) must be
folded and assembled into dimers with G protein γ subunits (Gγ) or regulators of G protein
signaling (RGS) proteins. They are assisted in this process by the cytosolic chaperonin CCT,
which specializes in folding proteins with β-propeller motifs like Gβ. CCT acts in concert with
the co-chaperone phosducin-like protein 1 (PhLP1) to complete the Gβ folding and assembly
process. To understand this process at the molecular level, we have isolated a folding
intermediate of Gβ5 bound to CCT and determined its structure to 3.4 Å resolution by highresolution cryo-electron microscopy (cryo-EM). Gβ5 is the least conserved of the five Gβ
isoforms, which is recapitulated biochemically and structurally in the way Gβ5 interacts with
CCT. Previous studies show that Gβ1 binds to CCT at the rim of the folding chamber and is
released from CCT by PhLP1 to interact with Gγ. By contrast, Gβ5 sits deep inside the folding
chamber and PhLP1 reaches down from the rim of the folding cavity to stabilize Gβ5 inside the
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chamber. This structure explains why PhLP1 increases Gβ5 binding to CCT instead of releasing
it as is the case with Gβ1. Lastly, we examined CCT-dependent folding of a pathological S81L
mutant form of Gβ5 to understand the molecular defect caused by the mutation. Gβ5 S81L
showed decreased cellular expression but increased binding to CCT compared to the wildtype,
suggesting that the mutation is pathological because it prevents proper folding by CCT. The
mutation allowed us to determine a series of structures of the mutant bound to CCT. Over the
course of the series, the Gβ5 β-propeller ranges between partially open to closed states,
indicating that the mutation likely creates an energy barrier that prevents CCT from bringing the
N- and C- terminal portions of the Gβ5 β-propeller together. This finding provides a molecular
explanation for the physiological defects in Gβ5 caused by the S81L mutation and represents a
breakthrough in visualizing CCT substrate folding dynamics.

Introduction
G proteins mediate the transmission of a myriad of extracellular signals across the plasma
membrane to the inside of the cell. These signals include hormones, neurotransmitters, odorants
and photons of light, among many others. The bridge for the signal to traverse the plasma
membrane is the G protein coupled receptor (GPCR), a seven transmembrane helical structure
that binds to extracellular ligands and transmits information via conformational changes to the
cytoplasmic surface of the membrane. Inside the cell, the Gα, Gβ, and Gγ subunits of the G
protein heterotrimer interact with the activated GPCR [1], and the Gα subunit releases a
molecule of GDP and binds a new molecule of GTP. This nucleotide exchange allows the
heterotrimer to dissociate from the GPCR and travel along the inner membrane leaflet to activate
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downstream effectors [2]. In the GTP bound state, Gα loses its affinity for Gβγ and the
heterotrimer dissociates. Gα slowly hydrolyzes GTP to GDP, thereby inactivating the Gα.
However, for many Gα isoforms this process is accelerated by binding to Regulator of G protein
Signaling (RGS) proteins. In neurons, the R7 family of RGS proteins interacts with a specialized
form of Gβ (Gβ5) to bind Gα and accelerate its GTPase activity [3].
Before G proteins can be functional, they must first be folded and assembled into
heterotrimers [4]. After G proteins are synthesized by the ribosome, a network of chaperones is
present to help them fold [5]. A primary chaperone for the Gβ subunit is the cytosolic chaperonin
CCT and its co-chaperone phosducin-like protein 1 (PhLP1) [6-8]. CCT is composed of two sets
of eight paralogous subunits that form two back-to-back rings, thus forming a barrel-shaped
structure into which nascent proteins can enter to be protected from the cytosolic environment
until they are properly folded. Each subunit is composed of equatorial, intermediate, and apical
domains [9]. The equatorial domains bind ATP and form the inter-ring contacts [10, 11]. The
apical domains are on the outer rim of the barrel and shift upon ATP hydrolysis as a rigid body
to seal off the end of the barrel [10]. The intermediate domains propagate the conformational
changes from the equatorial domains to the apical domains.
CCT has been estimated to fold up to 10% of the cytosolic proteome [12], particularly
proteins with multiple domains and complex folding patterns [11, 13]. A major class of CCT
substrates are proteins with WD40 repeat sequences that fold into β-propeller structures [5]. There
are 262 β-propeller proteins in humans [14] and many of these use CCT for folding, including the
five G protein Gβ subunits [8], the Gβ-like (mLST8) and Raptor subunits of the mTORC1 complex
[15] and the BSS2 and BBS7 subunits of the BBSome [16, 17]. β-propeller proteins commonly
form seven β-sheets that are arranged into a circular, propeller-like structure. For β-propellers to
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fold completely, the N- and C-terminal portions of the β-propeller must be brought together to
form the last β-sheet. CCT is believed to help bring these two ends together as part of the folding
process.
Once the β-propeller is folded, CCT has been proposed to hold the protein until it can
interact with its binding partners [18]. This process has been studied biochemically for the Gβγ
and Gβ5-RGS dimers, and evidence indicates that the co-chaperone PhLP1 plays an important
role [4]. The Gβ isoforms 1-4 form dimers with the twelve Gγ isoforms in various combinations.
Cellular depletion of PhLP1 increases the binding of Gβ1 to CCT but decreases formation of
Gβγ dimers [4]. This finding indicates that PhLP1 releases Gβ1 from CCT so that Gβ1 can bind
Gγ subunits and form Gβγ dimers. By contrast, Gβ5 preferentially forms dimers with RGS
proteins of the R7 family and PhLP1 depletion decreases both the binding of Gβ5 to CCT and
formation of Gβ5-RGS dimers [4]. Furthermore, CCT only interacts with RGS7 when Gβ5 is
present [4]. These observations suggest that PhLP1 stabilizes the CCT-Gβ5 interaction until Gβ5
can bind to RGS proteins and be released from CCT.
While the general contribution of CCT to β-propeller folding is recognized, the molecular
mechanisms of how CCT influences the folding trajectory remains elusive. The ATP-dependent
conformational changes in CCT are believed to play an important role. In the absence of
nucleotide, CCT is in an open conformation that allows substrates to enter the chamber and bind
CCT. Upon ATP binding and hydrolysis, α-helical extensions on the apical domains enclose the
folding chamber and seal it off from the cytosol, creating a sequestered space for the protein to
fold [9, 11]. Phosphate release reverses the conformational change and reopens the folding
chamber, providing an opportunity for the protein to diffuse away from CCT. Mounting
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evidence suggests that the closure of the cavity is coordinated across CCT subunits, but precisely
how these movements correlate with substrate folding remains unknown. To understand better
the effects of ATP hydrolysis on CCT form and function, several structures have been solved of
CCT in different nucleotide states [10, 11, 13, 19]. These structures provide static images of
CCT in different conformations that reveal what residues interact in the different conformations.
However, details about how CCT transitions from one state to another and how much time CCT
spends in each state are still limited. Further, it is unknown what happens to the substrate as CCT
proceeds through the nucleotide cycle.
Substrates have been observed to bind at a variety of different locations on CCT. Actin
and tubulin bind near the apical domains of the CCT3, 6, and 8 subunits [11, 13]. Likewise, Gβ1
binds at the rim of the CCT cavity at the CCT3 subunit [8]. PhLP1 aids Gβ1 folding by bridging
the top of the CCT folding cavity and making contact with Gβ1 [8]. Surprisingly, the Gβ-like
mLST8 protein of the mTORC complexes binds in the center of the folding chamber between the
CCT rings and appears to fold without the help of PhLP1 [15]. Due to the differences in the role
of PhLP1 in Gβ5 folding compared with Gβ1, we questioned whether Gβ5 interacted with CCT
in a manner more similar to Gβ1 or rather more like mLST8.
To investigate the molecular mechanism whereby CCT and PhLP1 fold Gβ5, we
determined the structure of the PhLP1-Gβ5-CCT complex by high resolution cryo-electron
microscopy (cryo-EM). The structure shows Gβ5 in a near native conformation bound between
the CCT rings in the center of the complex. It also shows the PhLP1 C-terminal domain bound to
several CCT apical domains at the rim of the folding chamber with the N-terminal domain
reaching down to contact Gβ5. We also investigated the folding of the pathological S81L mutant
form of Gβ5 and found that this mutation impeded CCT from efficiently closing the Gβ5 β32

propeller. These results highlight fundamental differences in the way CCT and PhLP1
orchestrate the folding of Gβ5 and Gβ1 and they show how mutations disrupt the Gβ5 folding
process.

Results
The position of Gβ5 and PhLP1 in the CCT folding chamber
To understand better how CCT and PhLP1 interact to fold Gβ5, we isolated the folding
complex directly from HEK 293T cells. We developed a stable cell line expressing PhLP1 and
Gβ5, which we used to pull down the complex using a tandem affinity purification strategy. We
obtained sample of sufficient yield and purity for structural studies (Figure 2-1A).
The sample was applied to gold grids, plunge frozen and imaged on a Titan Krios
microscope. After 2D and 3D classification of the particles, we achieved a consensus
reconstruction of the complex at 3.4 Å resolution (Figure 2-1C,
Figure 2-2A). The greatest resolution was achieved in the CCT equatorial domains. The
flexible intermediate and apical domains were less structured and had lower resolution in the
final model (
Figure 2-2C). The unique orientation of the apical domains allowed us to unambiguously
dock a previous structure (PDB:6QB8) of human CCT into the cryo-EM reconstruction.
After docking in CCT, two additional densities remained in the EM map (
Figure 2-2B). One density was roughly toroid shaped with a central hole and was
positioned between the two CCT rings near the equatorial domains of the CCT3 and 6 subunits.
The location of this density corresponded with the previously observed
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Figure 2-1 Structural Determination of Gβ5-CCT complexes. A) Coomassie staining of purified complex with immunoblots
identifying each band. B) Example cryo-EM micrograph. C) Processing workflow of the various Gβ5:CCT complexes
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location of mLST8. The second density was positioned near the entrance of the folding chamber
making contact with the apical domains of CCT3, 6 and 8. Gel electrophoresis indicated that the
complex was isolated with a high level of purity and had bands consistent with the mass of Gβ5
and PhLP1. Immunoblotting confirmed that these bands where Gβ5 and PhLP1 (Figure 2-1A).
Mass spectrometry analysis also had Gβ5 and PhLP1 as top hits (Table 1). We therefore
concluded that the two densities must represent Gβ5 and PhLP1.

Figure 2-2 Structural Determination of the wildtype Gβ5-PhLP1-CCT complex by cryo-EM. A) Side and end on
views of the Gβ5-PhLP1-CCT complex. B) Central slice of the complex showing two densities inside the cavity C)
Local resolution of the Gβ5-PhLP1-CCT reconstruction. Red 3.072 Å, Yellow 4.971 Å, Green 6.869 Å, Cyan 8.768
Å, Blue, 10.67 Å

We performed extensive particle sorting on the dataset and isolated a class of particles in
which an additional third density was present that nearly mirrored the apical domain mass on the
opposite end of CCT (Figure 2-1C). These two masses both interacted primarily with the CCT6
apical domains and made additional contacts with the CCT8 apical domains. Both masses were
of roughly equal size, suggesting they could be the same protein.
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Table 1 Top proteomic hits of purified Gβ5-PhLP1-CCT sample.

Because the resolution of these densities was not high enough to unequivocally attribute
them to Gβ5 or PhLP1, we used chemical crosslinking coupled with mass spectrometry to aid in
docking Gβ5 and PhLP1 into these densities (Figure 2-3A-C). This analysis revealed that Gβ5
made extensive contacts with the N- and C- termini and equatorial domains of several CCT
subunits. No crosslinks were observed between Gβ5 and any CCT apical domains. These
crosslinks indicate that the toroid shaped density in the center of the CCT folding chamber
represents the β-propeller of Gβ5. Indeed, the dimensions of the density fit Gβ5 well. For PhLP1,
crosslinks between the C-terminal thioredoxin domain of PhLP1 and the apical domain of CCT3
suggest that the apical mass likely represents this domain of PhLP1. We also observed crosslinks
between Gβ5 and the thioredoxin domain of PhLP1. Additional crosslinks between the Nterminus of PhLP1 and the equatorial domains of several CCT subunits suggest that the PhLP1
N-terminus extends into the folding cavity and makes contact with Gβ5. Intra-protein crosslinks
indicate that PhLP1 and Gβ5 are in a near native state. Multiple Gb5 intra-links were identified
spanning the N- and C-terminal β-strands in the first β-sheet of the β-propeller (Figure 2-3B).
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This observation indicates we isolated a folding intermediate in which the Gβ5 β-propeller is
already closed.

Figure 2-3 Docking Gβ5 and PhLP1 into the EM density. A) All crosslinks identified mapped onto the ribbon
structures of Gβ5 (blue), PhLP1 (red) and CCT (tan). Side panels highlight crosslinks between Gβ5 and PhLP1. B)
Intraprotein Gβ5 crosslinks. C) Distribution of crosslink Cα-Cα Euclidean distances. D) Gβ5 and PhLP1 docked in
the cryo-EM density. E) Overlay of the EM density maps of mLST8-CCT (EMDB:4489, cyan) and Gβ5-PhLP1-CCT
(tan)Conformational dynamics of nucleotide free CCT

Conformational dynamics of nucleotide free CCT
Due to the large number of particle images collected from the Gβ5-PhLP1-CCT dataset,
we were able to perform conformational analysis on the data using the 3D Variability Analysis
functionality in CryoSparc3.2 [20]. Using this feature, we were able to observe several modes of
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variability in the apical regions of several CCT subunits. We observed large shifts in the CCT2, 7
and 1 subunits (Figure 2-4A). Previous work with yeast CCT has shown that these subunits are
most sensitive to the addition of the ATP transition-state analog ADP-AlFx [10].

Figure 2-4. Conformational Variability in CCT subunits. A) Range of motion in individual subunits from one
extreme (gold) to the other (gray). PDB accession numbers for ribbon structures, if available, are listed below each
image. B) Bi-axial pinching motion. Notice how the gray model is generally closer to the center of the cavity than is
the gold model. C) Partial closure of the CCT cavity with Gβ5 and PhLP1 bound inside.
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Similar changes are observed between the nucleotide free (PDB:5WG4) and AMP-PNP
(PDB:5WG5) bound structures of yeast CCT [19]. Our variability analysis indicates how CCT
can transition between these known states. We also observed a bi-axial pinching motion in the
equatorial domains of CCT, where the CCT2 and CCT6 are pinched together, decreasing the
diameter of the folding cavity (Figure 2-4B). This motion has been theorized [21], but has not
been experimentally observed until this point. Lastly, we observed a partial closure of the CCT
folding chamber with Gβ5 and PhLP1 bound to CCT (Figure 2-4C). These movements are not
likely due to ATP hydrolysis because no nucleotide was added to the sample during purification.
Instead, these motions represent the natural flexibility of CCT in solution before it binds ATP.
Intriguingly, the flexing of the apical domains was random with no coordinated conformational
changes between subunits, indicating variability in the order in which the CCT subunits close in
the absence of nucleotide [10].

Gβ5 S81L is a folding mutation that prevents CCT from folding the Gβ5 β-propeller
With this understanding of how wildtype Gβ5 interacts with CCT and PhLP1, we next wanted to
determine if mutations in Gβ5 interfere with the folding process. We identified the S81L
mutation in Gβ5 as a potential folding mutant. This mutation carries significant pathological
consequences as patients harboring the S81L Gβ5 mutation exhibit hyperactivity, speech
impairment, and motor delay [22]. The mutation decreases the stability of Gβ5 in neurons and
leads to decreased RGS9-Gβ5 mediated termination of dopaminergic signaling [22]. Serine 81 is
located on the second β-strand of the second β-sheet in the Gβ5 β-propeller. Mutation of this
serine to leucine disrupts a hydrogen bond with the backbone of V108 and results in steric
clashes with neighboring residues [22] (Figure 2-5A). We therefore predicted that the mutation
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prevented CCT from adequately folding Gβ5. To test this theory, we expressed Gβ5 S81L in
HEK 293T cells and measured the amount of CCT that co-immunoprecipitated with Gβ5. We
found that the mutation caused a 70% reduction in Gβ5 expression compared with wildtype, as
would be expected for a folding mutant, but it resulted in a 210 % increase in binding to CCT
compared to wildtype (Figure 2-5B). This result suggests that CCT has trouble releasing the
mutant form of Gβ5 and supports our hypothesis that S81L interferes with the CCT folding
process.
To investigate the possible folding defect in Gβ5 S81L, we again employed cryo-EM to
determine the structure of the complex. HEK293T cells were transiently transfected with Gβ5
S81L and purified using the same tandem affinity purification approach as before. After applying
the sample to gold grids and plunge freezing, 1.2 M particles were selected for 2D classification.
Of these, 963k were selected for 3D classification and further processing (Figure 2-1C). The
final reconstruction resulted in a 3.3 Å average resolution structure of the complex. The
structure did not appear to differ in any significant way from the previous Gβ5 wildtype
reconstruction (Figure 2-5C). We reasoned that the mutation did not change how Gβ5 bound to
CCT, but rather it affected the conformational dynamics of the folding process. To test this
possibility, we again employed the 3D Variability Analysis in CryoSparc3.2 [23]. After
analyzing the variability in the wildtype and mutant particle datasets, we clustered the particles
into 20 distinct classes (Figure 2-6, Figure 2-7). We then examined the shape of the Gβ5 toroid
in the center of the CCT cavity. We found that in the mutant dataset, the cluster classes all fit
into three superclasses: those with a complete toroid ring (258,258 particles (27%)); those with
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an open crescent shaped structure (371,993 particles (39 %)); and those with amorphous density
(333,620 particles (35 %)) (Figure 2-5D). In contrast, the wildtype dataset did not contain any

Figure 2-5 Structural analysis of mutant S81L Gβ5-PhLP1-CCT. A) Location of the S81L mutation locus depicted
by an orange sphere. B) HEK294T cells were transfected with wildtype or S81L Strep-tagged Gβ5 and PhLP1. The
cells were lysed and immunoprecipitated with Strep resin. The samples were then analyzed by gel electrophoresis
and immunoblotted as shown. C) Comparison of mutant (gray) and wildtype (tan) complexes. D) Representative
views of crescent shaped S81L Gβ5, closed S81L Gβ5, and closed wildtype Gβ5 from 3D variability analysis
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crescent shape classes, but rather only the complete ring (414710 particles (85%)) and
amorphous density classes (71840 particles (15%)) (Figure 2-5D). Thus, we observed a 20 %
increase in the percentage of mutant over wildtype particles that were in the amorphous density

Figure 2-6 Classes of wildtype Gβ5 identified by 3D variability analysis. A) Complete ring classes. B) Amorphous
classes. The number of particles present is indicated for each class.
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Figure 2-7 Classes of mutant S81L Gβ5 identified by 3D variability analysis. A) Crescent shaped classes. B) Ring
shaped classes. C) Amorphous classes. The number of particles present is indicated for each class.
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classes. We predict that the complete ring superclass represents the Gβ5 β-propeller in a nearly
native fold, while the crescent superclass represents the β-propeller in an open conformation
Lastly, the amorphous classes represent unfolded Gβ5. Because the mutant dataset contains both
the open and closed conformations, it appears that the S81L mutation inhibits the ability of Gβ5
to close into its native β-propeller state. We also binned the particles in a continuum of classes
along the principal components of the variability analysis and observed that the S81L β-propeller
adopted a continuous set of conformations between the open and closed states.

Discussion
The evidence presented here indicates that Gβ5 is folded by CCT in a manner distinct
from Gβ1 and mLST8. The high-resolution structure of the Gβ5-PhLP1-CCT folding
intermediate elucidates how Gβ5 folding may occur and affords a possible explanation for the
different biochemical behavior observed for Gβ1 and Gβ5, particularly in regard to the role of
PhLP1. Likewise, while the Gβ5 β-propeller binds in approximately the same position between
the CCT rings as mLST8 (Figure 2-9A, D), PhLP1 plays a unique role in interacting with Gβ5
that is not observed for mLST8 folding. It is intriguing that Gβ5 does not bind to CCT in the
same location as Gβ1 at the apical domains of CCT (Figure 2-9A, B). Gβ1 interacts with CCT
primarily through its N-terminal α-helix [8] and it was believed that this interaction keeps Gβ1
sequestered at the rim of the CCT cavity [15]. Gβ5 also has a similar α-helix (Figure 2-8), but
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this feature does not appear to be sufficient to make it bind at the rim of the CCT cavity. In fact,
the α-helix is the region that is least conserved between the two.

Figure 2-8 Sequence alignment of Gβ1 and Gβ5. N-terminal regions are indicated in purple. Overall sequence
homology: 52.4%; N-terminal homology: 27.9%.

The structural differences between the Gβ1 and Gβ5 folding complexes help explain the
biochemical differences between the Gβ1 and Gβ5 folding trajectories. For example, Gβ1 binds
to CCT much more tightly than Gβ5 in the absence of PhLP1 [4, 6]. The presence of PhLP1,
however, decreases the affinity of Gβ1 for CCT and increases the affinity of Gβ5 for CCT [4].
These data suggest that PhLP1 releases Gβ1 from CCT and stabilizes Gβ1 by dimerizing with it
until it can bind to Gγ [4, 6]. PhLP1 binds to Gβ1 at the periphery of CCT where the complex
can easily dissociate [8]. Gβ1 can also be readily purified in the absence of PhLP1 by washing
the complex with a modest level of salt [8]. By contrast, our attempts at purifying the Gβ5
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complex in the absence of PhLP1 were unsuccessful. Salt washes were insufficient to remove
PhLP1 from the complex and not co-transfecting PhLP1 with Gβ5 resulted in large amounts of
endogenous PhLP1 being pulled down with the complex. This is consistent with biochemical
data that PhLP1 increases the affinity of Gβ5 for CCT. Our structure shows that Gβ5 is buried
deep within the CCT folding chamber and will not readily dissociate with PhLP1 bound. Rather,
PhLP1 makes contact with Gβ5 and stabilizes it on CCT.

Figure 2-9 Comparison of substrate-CCT structures. End on and side slices of structures of the A) Gβ5-PhLP1CCT, B) Gβ1-CCT, C) Gβ1-PhLP1-CCT, and D) mLST8-CCT complexes. Substrates are shown in red.

Apart from PhLP1 binding, the Gβ5-CCT structure bares many similarities to the
mLST8-CCT structure. Both have β-propeller shaped masses in the center of the cavity.
Furthermore, several thin masses extend from the CCT5, CCT7, CCT8, CCT6, CCT1 and CCT3
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termini and contact the substrate (Figure 2-3E) [15]. These thin masses overlap very closely
between the mLST8-CCT and Gβ5-PhLP1-CCT reconstructions and make up the entirety of the
connections between CCT and the β-propellers. This suggests that the termini do have some
degree of structure and are not as disordered as previously thought [15]. They likely make
nonspecific contacts with the substrate, allowing them to accommodate a large variety of
substrates in between the rings.
It is perhaps these connections to the termini that prevent CCT from releasing Gβ5. The
termini are involved in a network of inter-subunit and inter-ring connections that govern
cooperative ring closure [10, 11]. Specifically, the CCT4 subunit is believed to act as a gatekeeper for ring closure
Based on our structure, PhLP1 appears to be playing a novel role in the way it is aids
CCT in the folding of Gβ5. PhLP1 appears to be stabilizing Gβ5 on CCT. The importance of
PhLP1 for Gβ5 expression has been demonstrated in mouse rod [18] and cone [25]
photoreceptors and in striatal neurons [26]. Previous structural observations of PhLP1 indicated
that it bridged across the CCT folding cavity [8, 27, 28]. Notably, this is what was observed for
the Gβ1-PhLP1-CCT complex [8]. We also observed PhLP1 binding in this manner in some of
our 2D and 3D reconstructions. However, the vast majority of particles had the thioredoxin
domain of PhLP1 binding to the CCT6 apical domain and N-terminal domain reaching down into
the cavity to make contact with Gβ5. The fact that we observe PhLP1 both bridging across CCT
and reaching down into the cavity suggests that PhLP1 is in equilibrium between the two states.
Our crosslinking data support this PhLP1 binding heterogeneity as crosslinks were found from
the N-terminal PhLP1 region to both the CCT termini in the center of the cavity as well as to the
apical domains of several CCT subunits. Likely, the conserved thioredoxin domain anchors
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PhLP1 to CCT and the flexible N-termini can switch positions to accommodate different
substrates. This interaction is similar to the homologous phosducin-Gβγ complex [29]. In this
complex (PDB:1A0R), the N-terminus of phosducin makes extensive contacts with Gβ1 βpropeller while the C-terminal thioredoxin domain only interacts peripherally with Gβ1.
The structures presented here provide novel insight into β-propeller folding by CCT. It is
thought that CCT binds to β-propellers late in their synthesis as the last few β-sheets emerge
from the ribosome [5]. The role of CCT seems to be to stabilize the β-propeller until the N- and
C- termini can loop around to interact with each other. CCT then holds on to the substrate until it
can interact with downstream binding partners. We observe that the Gβ5 β-propeller binds to
CCT in between the rings and spans both folding cavities.
These results give insight into the mechanism whereby CCT folds Gβ5. Based on our
results, we propose a general model of how CCT folds β-propeller proteins. A β-propeller is
synthesized by the ribosome and interacts with the substrate recognition sites on the apical
domains of CCT co-translationally [5, 24]. The substrate then drops down into the cavity where
it waits between the CCT rings until its binding partners are available to release it from CCT.
Additional research is needed to elaborate this model, including early-stage reconstructions of
substrates being bound co-translationally with CCT as well as late-stage reconstructions of
substrates being released from CCT by a binding partner, such as RGS7 [4, 7].
Lastly, we provide a molecular mechanism for the pathologies associated with the S81L
Gβ5 mutation. This mutation has been reported to prolong dopaminergic signaling and cause a
decrease in expression in Gβ5 [22]. Here, we show that these effects are due to impaired folding
in Gβ5 S81L.Our extensive classification of Gβ5 S81L-CCT particles demonstrate the presence
of a local minimum in the folding landscape where the Gβ5 β-propeller is open. Thus, the
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mutation prevents CCT from efficiently closing the Gβ5 β-propeller. This insight suggests a
potential avenue for rescuing Gβ5 function in individuals harboring this mutation.

Methods
Cell culture
Human embryonic kidney (HEK)-293T cells (ATCC) were grown in 10% fetal bovine
serum (FBS) in DMEM/F12 media. Cells were passaged to maintain confluency between 1090% and passage number was kept under 20.
A line of HEK-293T cells were transduced with pLentiPuro (Addgene #39481) virus
containing PhLP1 C-terminally tagged with His6 and myc. The cells were then treated with
puromycin for several passages to select for transduced cells. The cell line was then treated with
pLenti virus containing the Gβ5 long variant with an N-terminal 2x Strep tag and a C-terminal
HPC4 tag and a blasticidin resistance gene. The cells were then treated with blasticidin for
several passages to select for transduced cells. The cell line was then frozen in aliquots and used
as a stable cell line for Gβ5-PhLP1-CCT isolation.

Immunopreciptitation
HEK-293T cells were cultured and transfected in six-well plates. Cells were washed in
PBS and lysed in 200 μL of PBS supplemented with 1 % IGEPAL, 0.5 mM PMSF and Halt
Protease Inhibitor Cocktail (Sigma P8340). Protein concentrations were determined using the
DC protein assay (BioRad 5000116) and equal protein amounts (~ 400 μg) were
immunoprecipitated by addition of epitope tag antibodies, followed by 30 μL of protein A/G
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agarose beads (Santa Cruz). Immunoprecipitants were washed three times in lysis buffer, then
resuspended in SDS-PAGE loading buffer. Proteins were separated by SDS-PAGE and
transferred to nitrocellulose (Biorad Transblot). The nitrocellulose was probed with the
indicated primary antibodies and IRDye secondary antibodies (Li-COR). Blots were imaged
using a LI-COR Odyssey infrared scanner, and proteins were quantified with the LI-COR
software.
The effects of ATP on the co-immunoprecipitation of Gβ5 with CCT was performed in a
cell line expressing a Flag-tagged CCT3 subunit, described previously [15]. These cells were
transfected with PhLP1 and either wildtype or S81L N-terminally 2x Strep tagged Gβ5. We then
performed an immunoprecipitation as described above using Flag antibody. After two washes in
lysis buffer containing 1 % IGEPAL, samples were incubated at 4°C in this buffer for an
additional three hours during which 5 mM ATP was added after 0, 1 or 2 hrs so that samples
were incubated in ATP for a total of 1, 2 or 3 hrs. The zero sample was incubated without ATP
for 3 hrs. Following the incubation, samples were washed two more times and then
immunoblotted as described.

Isolation of Gβ5-PhLP1-CCT
Cells from the Gβ5 and PhLP1 expressing stable cell line were cultured as previously
described. Cells were grown to 80 % confluency in T-175 tissue culture flasks and harvested in
lysis buffer consisting of 1% IGEPAL in PBS with 0.5 mM PMSF and Halt Protease Inhibitor
Cocktail. For the S81L Gβ5 complex, cells were transfected with 45 μg of N-terminal 2x Strep
Gβ5 S81L in pcS2+ vector and with 45 μg C-terminal tagged His6-myc PhLP1 in pcDNA3.1B+
and 200 μg of polyethylenimine (PEI). Cells were lysed as before. The lysates were then
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subjected to centrifugation at 30,000 x g for 20 minutes and filtering through 0.45 μm and 0.2
μm filters.
The Gβ5-PhLP1-CCT complexes were purified by tandem affinity purification (TAP) at
4° C. The filtered lysate was passed over a HisTrap HP 5 mL column (GE17-5248-01)
equilibrated with 20 mM HEPES, 20 mM NaCl, 25 mM imidazole, 0.05% CHAPS, 1 mM
TCEP, pH 7.5 for 1 hour. The column was washed with 5 column volumes of equilibration
buffer and eluted with linear gradient of 8 column volumes of 25 mM to 500 mM imidazole.
Eluted fractions were analyzed by SDS-PAGE and Coomassie staining. Fractions containing
mLST8 and CCT were combined and loaded onto 5 mL of Strep-Tactin resin (Iba 2-1201-010)
equilibrated with 20 mM HEPES pH 7.5, 20 mM NaCl for 1 hour. The column was washed two
times with one column volume of 20 mM HEPES pH 7.5, 150 mM NaCl, 0.05% CHAPS, and
then twice with one column volume of 20 mM HEPES pH 7.5, 20 mM NaCl, 0.05% CHAPS.
The Gβ5-PhLP1-CCT complexes were eluted with 3 column volumes of 20 mM HEPES pH 8.0,
20 mM NaCl, 0.05% CHAPS, 5 mM D-desthiobiotin and concentrated to 1 μg/μL using a 30
kDa cutoff filter (Amicon UFC803024) and analyzed by SDS-PAGE and Coomassie staining
and immunoblotting. Where noted, some of the sample was crosslinked with 0.05 %
glutaraldehyde for 5 min and quenched with 50 mM Tris-HCl.

Crosslinking
100-300 μg of Gβ5-PhLP1-CCT complex were mixed with sulfo-LC-succinimidyl
diazarine (SDA) (Millipore-Sigma 803413) in 20 mM HEPES, 20 mM NaCl, 5 mM MgCl2, pH
8.0 in 4:1 SDA:protein mixture for one hour at room temperature. The succinimidyl reaction was
then quenched with 50 mM Tris-HCl for 15 min. The solution was then placed in a 6 well dish
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on ice and irradiated with 365 nm light for 30 min using a preheated Analytik Jena CL-3000L
UVP crosslinker (649.9 mJ/cm2). The sample was then denatured in 6 M guanidine-HCl, 100
mM Tris-HCl, 25 mM methylamine, pH 8.5 and concentrated to 90 μL using a microcentrifuge
filter. Next, the sample was reduced with 5 mM TCEP at 37°C for an hour, and then alkylated
with 10 mM iodoacetamide for 30 min in the dark at room temperature. The sample was diluted
with 50 mM ammoninium bicarbonate and trypsin digested (Promega V5111) (1:50
enzyme:substrate) at 37°C overnight. The peptide fragments were then isolated using 100 μL
C18 tips (Pierce 87784) and eluted with 70:30:0.1 water:acetonitrile:trifluoroacetic acid (TFA).
The peptides were then dried using a vacuum concentrator and reconstituted in 0.1 % TFA.

Mass Spectrometry
The enriched crosslinked peptide samples were separated using a Thermo Fisher
Scientific EASY-nLC 1000 Liquid Chromatograph system with a 15 cm Picofrit column (New
Objective) packed with Reprosil-Pur C18-AQ of 3 μm particle size, 120 Å pore size. Mobile
phase A consisted of water and 0.1% (v/v) formic acid (FA) and mobile phase B consisted of
80% (v/v) ACN and 0.1% (v/v) FA. Peptides were loaded onto the column with 1% buffer B at
700 nL/min flow rate and eluted at 300 nL/min flow rate with the following gradient: 1 min
linear increase from 1 to 11% mobile phase B followed by 169 min increase to 44%, and 3 min
to 100% mobile phase B [30]. The column was coupled via electrospray to an Orbitrap Fusion
Lumos Tribrid Mass Spectrometer. The resolution of MS1 was 30,000 over a scan range of 3802000 m/z. Peptides with a charge state +3 and greater were selected for HCD fragmentation at a
normalized collision energy of 35% with 3 steps of 10% (stepped NEC) and a resolution of

52

7,500. Dynamic exclusion was enabled with a 10 ppm mass window and a one-minute time
frame. Samples were run in duplicate.

XL-MS analysis
Crosslinks were identified from the spectra using the Xi software suite
(xiSearch_1.7.651, xiFDR_1.1.7). A database of peptide sequences was created with amino acid
sequence of Gβ5, PhLP1 and the eight human CCT subunits (UniProt ID: O14775-1, Q13371,
P17987, P78371, GenBank: CAA52808.1, P50991, P48643, P40227, Q99832, P50990
respectively). Several common contaminant proteins were also included in the database
(UniProt: P0DMV9, P0DMV8, P11142, P34931, P08238, P17066, Q71U36, P68363, Q9BQE3)
The search was with a mass tolerance of 6 ppm, 4 missed cleavages (trypsin), fixed
carbamidomethylation C) and variable oxidation (M) modifications. A custom LC-SDA
crosslinker was used (Asymetric, Mass:195.125812, First Linked Amino Acid:*, Second linked
amino acid: K, T, S, Y, N-terminus). The results were filtered with a FDR less than 10 %.

Cryo-EM grid preparation and image acquisition
Cryo-EM grids were prepared with a Vitrobot Mark IV (FEI) at 22 ºC and 95%
humidity. Aliquots of 4 μl of human Gβ5-PhLP1-CCT complex or were applied to a glow
discharged gold grid (UltrauFoil 1.2/1.3). Cryo-EM imaging was performed at the University
of Utah with a FEI Titan Krios electron microscope (Krios 1) operating at 300 kV, equipped
with a Gatan K3 Summit direct electron detector mounted on a Gatan Bioquatum LS/967
energy filter. Data collection was carried out with a nominal magnification of × (yielding a
pixel size of 1.04 Å/pixel), at a defocus range of −1.5 to −3.0 μm. Movies were recorded and
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fractionated to 40 frames with a total exposure of 7 s. The dose rate was 8.6 e-/pixel/s for a
total dose of 60 e−/Å2 on the specimen.

Wildtype Dataset Image Processing
The 5799 movies of glutaraldehyde crosslinked Gβ5-PhLP1-CCT were aligned using the
Patch Motion Correction job of Cryosparc. (unless stated otherwise, Cryosparc v3.2.0 was used
in all subsequent steps). The motion correction output was then subject to CTF determination
using the Patch CTF estimation job. Images were sorted to exclude particles with a defocus
greater than 3.5 μm and a CTF resolution estimate greater than 10 Å. Particles were then
picked using CCT template classes of end on and side views. Particles had a box size of 320
pixels. Two dimensional classification was then performed to exclude bad particles. The best
classes were used to create an ab-initio model with no symmetry imposed. The model
resembled a cylinder with the same dimensions as CCT. Heterogeneous refinement was then
performed to sort out classes containing one (92,499 particles) or two (134,993 particles)
apical masses. Non-uniform refinement was performed on each class from the heterogeneous
refinement, yielding reconstructions of 3.62 Å for the single apical mass class and 3.53 Å for
the double mass class.

Variability Analysis
4710 movies of wildtype and 5314 movies of S81L Gβ5-PhLP1-CCT sample (not
crosslinked) were processed as described for the wildtype crosslinked dataset. Particles were
extracted with a box size of 256 pixels. Two dimensional classification was then performed to
exclude bad particles. The best classes (502,061 particles for wildtype, 1,213,810 particles for
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S81L) were used to create an ab-initio model with no symmetry imposed. Homogeneous
refinement was then performed on 486,550 particles for the wildtype dataset and 963,871
particles for the S81L dataset yielding structures of 3.40 Å for the wildtype dataset and 3.25 Å
for the S81L dataset.
The variability analysis was performed and 20 classes of particles were determined for
each dataset. These classes were then manually sorted at the same threshold cutoff into classes
containing a complete Gβ5 ring, a partial Gβ5 ring, or amorphous density. The top three
estimated major modes of variability were also calculated for the wild-type and S81L datasets.
To observe the movement of the CCT apical domains, C2 symmetry was imposed for an
additional round of 3D variability analysis.
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Abstract
The mechanistic target of rapamycin (mTOR) kinase forms two multi-protein signaling
complexes, mTORC1 and mTORC2, which are master regulators of cell growth, metabolism,
survival and autophagy. Two of the subunits of these complexes are mLST8 and Raptor, βpropeller proteins that stabilize the mTOR kinase and recruit substrates, respectively. Here we
report that the eukaryotic chaperonin CCT plays a key role in mTORC assembly and signaling
by folding both mLST8 and Raptor. A high resolution (4.0 Å) cryo-EM structure of the human
mLST8-CCT intermediate isolated directly from cells shows mLST8 in a near-native state bound
to CCT deep within the folding chamber between the two CCT rings, and interacting mainly with
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the disordered N- and C-termini of specific CCT subunits of both rings. These findings describe
a unique function of CCT in mTORC assembly and a distinct binding site in CCT for mLST8,
far from those found for similar β-propeller proteins.

Introduction
The mTOR (mechanistic target of rapamycin) protein kinase is a master regulator of cell
growth, metabolism and survival, and as such, it constitutes a high-value drug target [2]. mTOR
interacts with mLST8 (mammalian Lethal with SEC13 protein 8) and Raptor (Regulatory
associated protein of mTOR) to form mTOR complex 1 (mTORC1) [3], or with mLST8, Rictor
(rapamycin-insensitive companion of mTOR), and mSIN1 (mammalian stress-activated MAP
kinase-interacting protein 1) to form mTOR complex 2 (mTORC2) [4]. These complexes are
functionally distinct as mTORC1 is activated by growth factors and amino acids to promote
protein, lipid and nucleic acid synthesis and inhibit autophagy, while mTORC2 functions
upstream of mTORC1 in growth factor signaling to activate cell survival pathways by
phosphorylating the kinases AKT, PKC and SGK1 [2].
In order to perform their signaling functions, the mTOR complexes must be assembled
from their nascent polypeptides. Protein complex assembly is often mediated by molecular
chaperones that assist nascent or misfolded proteins to achieve their native structures and
assemble into functional complexes [5]. Protein folding and complex formation seldom occurs
spontaneously in the very concentrated protein environment of the cell, but requires chaperones
to protect proteins from aggregation, to channel their folding pathways and to facilitate their
association into multi-protein assemblies [5]. The mTOR kinase is a 289 kDa protein that
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requires the Hsp90 chaperone and the Tel2-Tti1-Tti2 (TTT)-R2TP co-chaperone complex to fold
properly [6, 7]. However, little is known about how the other mTORC components are folded
and brought together with mTOR. Yeast genetic studies have pointed to a possible role for the
cytosolic chaperonin containing TCP-1 (CCT, also called TRiC) in mTOR complex formation.
Over-expression of CCT subunits suppressed phenotypes associated with temperature sensitive
mutations of yeast TOR and LST8, indicating a genetic interaction between CCT and the yeast
TOR complex [8, 9]. Furthermore, genetic disruption of CCT ATPase activity resulted in
phenotypes similar to those observed with loss of yeast TOR signaling [10]. These findings in
yeast are consistent with results from human interactome studies that identified interactions
between mLST8 and Raptor with CCT, but not with the other mTORC components [11].
CCT is a eukaryotic member of the chaperonins which are divided in two types: type I,
which is present in eubacteria and in organelles of endosymbiotic origin; and type II, which is
present in archaea and the eukaryotic cytosol. All are large oligomers that form a double-ring
structure [12, 13]. CCT is the most complex of all chaperonins with each of the two rings
composed of eight paralogous subunits (referred to here as CCT 1-8). At the center of each ring
is a protein folding chamber measuring approximately 60 Å in diameter [14] with a volume
large enough to encapsulate a 70 kDa protein [15]. Each of the subunits of CCT and the other
chaperonins can be divided into three domains: the equatorial domain, which hosts the ATP
binding site and most of the intra- and inter-ring interactions; the apical domain, which is
believed to be responsible for substrate recognition and binding; and the intermediate domain,
which acts as a linker between the other two domains. ATP binding and hydrolysis in the CCT
subunits induce conformational changes in the CCT structure that drive protein folding [16, 17].
Unfolded polypeptides bind within the folding chamber when CCT is in its open conformation
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and the nucleotide binding sites are empty [1, 18]. As ATP binds and the ATP hydrolysis
transition state is achieved, the chamber closes, due to the movement of a long α-helical
protrusion in each subunit, and the protein is trapped within the chamber [19-21]. This
entrapment assists folding by confining the degrees of conformational freedom of the
polypeptide and by influencing the folding trajectory [12, 13]. After ATP hydrolysis, the
chamber opens and if the protein has achieved a native fold and lost its contacts within the
chamber, it is released.
CCT assists in folding proteins with multiple domains or complex folds and helps to
assemble multi-protein complexes [1, 22]. Among these, proteins with β-propeller domains are
an important class of CCT folding substrates [23, 24]. β-propeller domains commonly consist of
seven WD40 repeat sequences that fold into seven β-sheets that form the blades of a propellerlike circular structure [25]. β-propellers have a unique folding trajectory that requires the Cterminus to interact with the N-terminus to make the last β-sheet that closes the β-propeller.
CCT may help bring the termini together and assist the β-propeller to close during folding [23].
These β-propeller domains have important functional roles from protein-protein interactions to
enzymatic catalysis. β-propeller proteins that are folded by CCT include G protein β subunits
(Gβ) [1, 26], the cdc20 and cdh1 components of the anaphase promoting complex [24], and the
protein phosphatase 2A regulatory subunits [27] among others.
Two of the subunits of mTOR complexes, mLST8 and Raptor, contain β-propeller
domains [3, 28]. mLST8 consists entirely of a single β-propeller that binds and stabilizes the
mTOR kinase domain [3, 28], while Raptor contains a C-terminal β-propeller [3, 29] that may
bind regulatory proteins [3, 30]. The mLST8 β-propeller shows strong structural homology with
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the β-propeller of Gβ [25, 28], further suggesting that mLST8 may be folded by CCT. To test
this possibility, we used functional and structural approaches to investigate the role of CCT in
mTORC formation and signaling. Our findings suggest that CCT contributes to mTORC
assembly and signaling by folding the mLST8 and Raptor β-propellers. We solved the structure
of the mLST8-CCT intermediate in mTORC assembly by cryo-EM to 4.0 Å. At this resolution,
the structure shows an almost native mLST8 β-propeller bound to CCT in an unexpected
position deep within the folding chamber between the two CCT rings, revealing a unique means
by which a β-propeller substrate is recognized by CCT.

Results
mLST8 and Raptor β-propellers bind CCT
To begin to examine the possible role of CCT in mTORC assembly and function, we sought to
confirm the interaction of mLST8 and Raptor with CCT reported in human interactome studies
[11]. We ectopically expressed human mLST8 or Raptor in cells and assessed their binding to
endogenous CCT by co-immunoprecipitation. With mLST8, we observed strong coimmunoprecipitation when either mLST8 or CCT5 was immunoprecipitated, indicating a robust
interaction between mLST8 and CCT (Figure 3-1a-b). Similar results were observed with
human Raptor and CCT5 (Figure 3-1c-d). To determine the domain of Raptor responsible for
the interaction, we expressed Raptor truncations containing the C-terminal β-propeller (residues
1000-1335) or the N-terminal caspase homology and armadillo repeat domains (residues 1-999)
and measured their binding to CCT by co-immunoprecipitation (Figure 3-1e-f). The C-terminal
β-propeller domain bound CCT robustly while the N-terminal domains showed no interaction,
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Figure 3-1 mLST8 and Raptor bind CCT . A) β-propeller structures of Gβ (PDB 1TBG) and mLST8 (PDB 4JT6).
The β-sheets are numbered according to convention with blade 7 containing β-strands from both the N- and Ctermini. B) Co-immunoprecipitation of mLST8 and CCT. HEK-293T cells were transfected with mLST8 or an empty
vector (EV), immunoprecipitated and immunoblotted as indicated. Co-immunoprecipitating bands are marked (red
asterisks). C) Raptor structure (PDB 5EF5) with β-sheets numbered as in panel a. (D-F) Co-immunoprecipitation of
Raptor and CCT. Cells were transfected with full length HA-tagged Raptor D), or HA-tagged constructs containing
the C-terminal β-propeller E) or the N-terminal caspase and armadillo domains F). Control cells were transfected
with empty vector as indicated. Cells were immunoprecipitated and immunoblotted as indicated. All blots are
representative of at least three separate experiments. G) ATP causes release of mLST8 from CCT. CCT
immunoprecipitates from cells over-expressing mLST8 were treated with 5 mM ATP for the times indicated, washed
and immunoblotted for mLST8 and CCT5. The amount of mLST8 remaining is shown as a percent of the no ATP
control. Error bars smaller than the symbols are not visible. H) ATP causes release of Raptor from CCT. The CCT
immunoprecipitation experiment was repeated with cells over-expressing Raptor.
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indicating that Raptor binds CCT through its β-propeller domain. We also tested the binding of
mTOR and the other core components of mTORC2, Rictor and mSIN1 to CCT by coimmunoprecipitation and found no interaction (Figure 3-2). Collectively, these findings
demonstrate interactions of the mLST8 and Raptor β-propellers with CCT and suggest that CCT
might be involved in their folding.
To further test the possibility that the mLST8 and Raptor β-propellers are folded by CCT,
we measured the effect of ATP on their co-immunoprecipitation with CCT. Substrates are
known to release from CCT in an ATP-dependent manner [31]. We incubated our CCT
immunoprecipitates containing mLST8 (Figure 3-1g) or Raptor (Figure 3-1h) with 5 mM ATP
and measured the amount of each that remained bound over time. ATP decreased mLST8 and
Raptor binding to CCT in a time-dependent manner, reaching a steady-state reduction of 60 %
with a half-life of 40 min for mLST8 and a steady-state reduction of 50 % with a half-life of 37
min for Raptor, indicating that both are indeed CCT folding substrates. These release rates are
significantly slower than the 7 min half-life reported for release of actin from CCT under
different in vitro conditions [32], suggesting that slow release may be a common property of
WD40 proteins.

CCT contributes to mTORC assembly and signaling
To assess the contribution of CCT to mTOR complex formation, we sought a method to
genetically deplete CCT from cells without compromising viability. The CCT complex is
essential and cannot be deleted without causing cell death over time. To resolve this issue, we
chose a CRISPR approach that decreased expression of CCT in a cell population significantly
without completely eliminating it (Figure 3-3a). In these cells, CCT expression was
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Figure 3-2. CCT contributes to mTORC assembly. A) Work flow of the CCT depletion experiments. Bold letters
correspond to the figure panels in which the experimental results are displayed. B) Effects of CCT depletion on
endogenous mTORC subunit expression. Cells were treated with CCT5 sgRNA or control sgRNA and Cas9, lysates were
immunoblotted and band intensities were quantified as indicated. Data are shown as a percent of the control. Bars
represent the average ± standard error. C) Effects of CCT depletion on co-immunoprecipitation of mTORC1 subunits.
Cells were CRISPR treated and transfected with the indicated mTORC1 subunits and a GFP control. mTOR
immunoprecipitates were immunoblotted and quantified as indicated. D) Lysates from cells in panel c were
immunoblotted and quantified for expression of mTORC1 subunits and controls as indicated. E) Effects of CCT
depletion on co-immunoprecipitation of mTORC2 subunits with mTOR. Cells were CRISPR treated and transfected with
the indicated mTORC2 components and a GFP control. mTOR immunoprecipitates were immunoblotted and quantified
as indicated. F) Lysates from the cells in panel e were immunoblotted and quantified for expression of mTORC2
subunits and controls as indicated. G) Effects of CCT depletion on co-immunoprecipitation of Gγ with Gβ. Cells were
CRISPR treated and transfected with Gβ, Gγ and a GFP control. Gβ immunoprecipitates were immunoblotted and
quantified as indicated. H) Lysates from the cells in panel g were immunoblotted and quantified for expression of Gβ
and Gγ and controls as indicated. I) Effects of siRNA-mediated CCT depletion on insulin-mediated IRS1 S636/639
phosphorylation or AKT S473 phosphorylation in HEPG2 cells. Cells were treated with siRNAs to CCT1/CCT5, mLST8,
Raptor or a non-targeting control, serum starved for 18 hours and then treated with insulin. Cell lysates were
immunoblotted as indicated. * p < 0.05, ** p < 0.01, *** p < 0.005.

reduced by 80 %, resulting in significant decreases in expression of endogenous mTOR (65 %),
mLST8 (40 %) and Raptor (50 %) but not Rictor, mSIN1 or the GAPDH control (Figure 3-3b),
indicating that the effect was specific. The changes in expression occurred post-transcriptionally
because CCT depletion had no effect on mTOR, mLST8 or Raptor mRNA levels (Figure 3-4a).
Thus, the decreases in mLST8 and Raptor expression are most likely due to their inability to
fold, while the decrease in mTOR expression may result from an inability to form stable
complexes in the absence of CCT.
To examine further the contribution of CCT in mTORC1 assembly, we ectopically
expressed mTOR, Raptor and mLST8 in CCT-depleted cells and assessed mTORC1 formation
by measuring the co-immunoprecipitation of Raptor and mLST8 with mTOR as well as the
cellular expression of each subunit. CCT depletion resulted in a 65 % decrease in mTOR
immunoprecipitation with corresponding decreases in mLST8 and Raptor coimmunoprecipitation (Figure 3-3c). This decrease in mTORC1 formation could be attributed to
similar decreases in mTOR, mLST8 and Raptor expression upon CCT depletion (Figure 3-3d).
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The effect appeared specific
because ectopic expression of GFP
or endogenous expression of
GAPDH was unchanged with the
loss of CCT (Figure 3-3d). The
decrease in mTORC1 components
upon CCT depletion is similar to
that seen with Gβ, a known CCT
folding substrate (Figure 3-3g-h),
but less than Gγ, a small 70 aminoacid protein that is rapidly
degraded when the Gβγ dimer
cannot form [26, 33]. Collectively,
these results suggest that CCT
contributes significantly to
mTORC1 formation. When CCT
is depleted, mLST8 and Raptor are
destabilized, which results in less
mTORC1 assembly and decreased

Figure 3-3. Raptor loss increases Rictor expression. A) Effects of CCT loss on
mTORC1 subunit mRNA levels. Cells were treated with CCT5 sgRNA or nontargeting sgRNA as in Figure 3-3, and endogenous mTOR, Raptor, and mLST8
mRNA levels were measured by qPCR. Data are shown as a percent of the
control. B) Effects of Raptor depletion on ectopic expression of mTORC2
subunits. Cells were treated with Raptor sgRNA or non-targeting sgRNA as in
Figure 3-3 and were transfected with mTORC2 subunits and a GFP control.
Lysates were immunoblotted and quantified for expression of mTORC2 subunits
and control proteins as indicated. Results are shown as a percent of the control.
* p < 0.05, *** p < 0.005.

mTOR expression.
In the case of mTORC2, CCT depletion did not change mTOR immunoprecipitation, but
it caused a decrease in mLST8 (50 %) and mSIN1 (30 %) co-immunoprecipitation (Figure 3-3e).
Unexpectedly, Rictor co-immunoprecipitation increased by 70 %. These changes generally
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paralleled the changes in ectopic expression of the subunits, which showed an increase in mTOR
(40 %), a striking increase in Rictor (300 %), a decrease in mLST8 (50 %) and no change in
mSIN1 (Figure 3-3f). The effects appeared specific because expression of the controls was
unchanged. These findings suggest that mLST8 incorporation into mTORC2 also depends on
CCT, but that CCT depletion significantly increases Rictor expression and association with
mTOR, perhaps as a result of decreased endogenous Raptor, given that Rictor and Raptor are
known to compete for mTOR binding [34]. To test this possibility, we measured the effects of
CRISPR-mediated Raptor depletion on ectopic expression of mTORC2 subunits. Raptor loss
resulted in an increase in Rictor expression, while there was little change in the other mTORC2
subunits (Figure 3-4b). These results suggest that CCT depletion decreases Raptor expression,
which causes compensatory increase in Rictor expression under these conditions.
CCT contributions to mTORC assembly should also be reflected in mTOR signaling. To
test this possibility, we assessed the effects of CCT depletion on mTOR-dependent
phosphorylation downstream of insulin in HEPG2 cells. Cells were siRNA-depleted of CCT and
treated with insulin. mTORC1 activity was assessed by IRS1 S636/S639 phosphorylation [35],
while mTORC2 activity was assessed by AKT S473 phosphorylation [36]. For comparison,
cells were also siRNA-depleted of mLST8 or Raptor. CCT depletion resulted in a 40 %
inhibition of both IRS1 and AKT phosphorylation, which was similar to the decreases observed
with mLST8 depletion (Figure 3-3i). Likewise, Raptor depletion caused a 50 % decrease in
IRS1 phosphorylation, but showed no change in AKT phosphorylation as expected (AKT is only
a substrate of mTORC2). These results support the idea that CCT participates in mTOR
signaling by assisting in the incorporation of mLST8 and Raptor into mTORC1 and mLST8 into
mTORC2.
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Figure 3-4 PhLP1 does not contribute to mTORC formation. A) Effects of PhLP1 depletion on endogenous mTORC subunit
expression. Cells were treated with PhLP1 sgRNA or non-targeting sgRNA and Cas9 as in Figure 3-3. Lysates were
immunoblotted and band intensities were quantified as indicated. Results are shown as a percent of control cells. Bars represent
the average ± standard error. B) Effects of PhLP1 depletion on co-immunoprecipitation of mTORC1 subunits with mTOR. Cells
were CRISPR treated and transfected with the indicated mTORC1 subunits and a GFP control. mTOR immunoprecipitates were
immunoblotted and quantified as indicated. C) Lysates from the cells in panel b were immunoblotted and quantified for
expression of mTORC1 subunits and control proteins as indicated. D) Effects of PhLP1 depletion on co-immunoprecipitation of
mTORC2 subunits with mTOR. Cells were CRISPR treated and transfected with the indicated mTORC2 subunits and a GFP
control. mTOR immunoprecipitates were immunoblotted and quantified as indicated. E) Lysates from the cells in panel d were
immunoblotted and quantified for expression of mTORC2 subunits and control proteins as indicated. F) Effects of PhLP1
depletion on co-immunoprecipitation of Gγ with Gβ. Cells were CRISPR treated and transfected with Gβ, Gγ and a GFP
control. Gβ immunoprecipitates were immunoblotted and quantified as indicated. G) Lysates from the cells in panel f were
immunoblotted and quantified for expression of Gβ and Gγ and control proteins as indicated. *** p < 0.005.

PhLP1 does not assist in mTORC assembly
The participation of CCT in mTOR complex formation raises the intriguing possibility
that the CCT co-chaperone PhLP1 may also be involved, especially since PhLP1 is required for
Gβ to fold and assemble into the Gβγ dimer [33]. To test this possibility, we used the same
CRISPR strategy to deplete cells of PhLP1 and measure the effects on mTOR subunit expression
and assembly. Unexpectedly, there was no decrease in expression of endogenous mTORC
subunits despite a 70% reduction in PhLP1 (Figure 3-5a). Likewise, there was no change in
formation of mTORC1 and mTORC2 (Figure 3-5b-e). In contrast, this same PhLP1 depletion
resulted in a striking 90 % decrease in Gγ association with Gβ as expected (Figure 3-5f and g).
These results argue against a contribution of PhLP1 to mLST8 or Raptor folding and highlight
differences between Gβ and mLST8 folding despite their structural similarities.

Cryo-EM structure of the mLST8-CCT assembly intermediate
To investigate the mechanism of mLST8 and Raptor folding by CCT, we sought to
isolate CCT-bound intermediates directly from cells and characterize their structures using cryoelectron microscopy (cryo-EM) and single-particle 3D reconstruction. We were successful at
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Figure 3-5 Cryo-EM image analysis of the mLST8-CCT complex. A) Electrophoretic analysis of the purified mLST8-CCT
complex, showing an SDS gel (left) and immunoblots for mLST8 and CCT2. B) An EM field of mLST8-CCT particles. Bar
indicates 500 Å. C) Maximum-likelihood 2D classification of the particles. Particles represented by the red-boxed classes
were discarded from further processing. D) Angular coverage of the particles used for the 3D reconstruction of the mLST8CCT complex. E) Plot of the FSC coefficients vs. Resolution between two independent reconstructions for the mLST8-CCT
complex using the gold-standard method. The resolution obtained for a signal to noise ratio (SNR) of 0.143 (4.0 Å) is
indicated. F) Local resolution map of the mLST8-CCT complex. Three views of the mLST8-CCT complex color coded
according to the level of resolution (left). Images correspond to the side (left), end on (center) and sliced end on (right)
views. The position of the slice is indicated in the cartoon at the top. Images were obtained with MonoRes. G) Histogram
with the resolution reached for each voxel of the 3D reconstruction.
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isolating human mLST8 bound to endogenous CCT from HEK-293T cells over-expressing
mLST8 using a tandem affinity chromatography strategy without adding exogenous nucleotide
(Figure 3-6a). However, Raptor-CCT complexes could not be readily isolated using a similar
strategy, possibly due to its large N-terminal domain which does not interact with CCT and
might result in a less stable complex. Therefore, we focused our structural characterization
efforts on the mLST8-CCT complex.

Figure 3-6 Atomic model of the human CCT complex. A) Docking of the atomic structure of yeast apo-CCT (PDB 5GW5)
into the 3D reconstruction of the mLST8-CCT complex. B) Atomic model of the human apo-CCT generated by homologymodelling from the yeast apo-CCT and subjected to flexible fitting and refinement.
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The purified mLST8-CCT complex was vitrified on grids and images were recorded with
a Titan Krios electron microscope (Figure 3-6b). A total of 1,769,600 particles were selected and
subjected to 2D classification (Figure 3-6c). The classes showed mostly the two typical views,
the end-on and side orientations, and the best classes (1,197,358 particles) were subjected to a set
of 3D classifications from which 452,000 particles were selected for further processing. The
angular coverage was very good (Figure 3-6d) and the final 3D reconstruction reached 4.0 Å
resolution after post-processing (Figure 3-6e). The resolution was not isotropic with the central,
equatorial domains yielding higher resolution than the flexible apical domains (Figure 3-6f and
g). The reconstruction shows human CCT in an open conformation with a prominent mass
located in the center of the structure between the two CCT rings (Figure 3-10a). The apical
domains have a very asymmetric arrangement in which the eight subunits in each ring are
arranged as a tetramer of dimers as observed previously for yeast CCT [14]. Besides the large
central mass, the structure is similar to those of bovine and yeast CCT in their open
conformations [14, 18, 32], in particular to the structure described by Zang et al. [14] for yeast
CCT in the AMP-PNP-bound conformation, despite the fact that the mLST8-CCT was purified
in the absence of added nucleotide.
Docking of the atomic model of yeast CCT in the AMP-PNP conformation [14] (PDB
5GW5) into the mLST8-CCT reconstruction confirms the similarity between the two structures
(Figure 3-7a). The docking is almost perfect in the equatorial domains and very good in the
intermediate and the base of the apical domains, which allowed us to unambiguously assign the
different subunits of the chaperonin in the mLST8-CCT complex (Figure 3-7a). The most
important differences in the docking are located in the helical protrusions, which are angled
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Figure 3-7 Comparison of substrate-free CCT and mLST8-CCT. A) Electrophoretic analysis of the purified substrate-free

CCT complex, showing an SDS gel (left) and an immunoblot for CCT2 (right). B) Three different views of the 3D reconstruction of
substrate-free CCT (7.5 Å resolution), showing end-on (left), side (center) and cut away side views (right). The arrow indicates a
mass in the interior of the cavity much smaller than that of mLST8. C) Left, cut away side view of the mLST8-CCT complex with the
resolution limited to that of substrate free CCT. The atomic structure of mLST8 (PDB 4JT6) is docked into the mass located between
the CCT rings. Center, an over-lay of mLST8-CCT and substrate-free CCT in the same cut-away view. Right, the same view of the
substrate-free CCT structure with the mLST8 molecule positioned at the same place as in the mLST8-CCT structure, showing a lack
of density attributable to mLST8 in the substrate-free structure.
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Figure 3-8 Cryo-EM structure of the mLST8-CCT complex. A) Top, the two end-on views of the 3D reconstruction of the mLST8-CCT

complex. Bottom, side view of the complex, either intact (left) or sliced through the center of the mass (right), to show the presence of the mLST8
molecule (red asterisks). B) Docking of the human CCT atomic model into mLST8-CCT 3D reconstruction. The color scheme for the CCT
subunits is kept the same in all the figures. Bar indicates 50 Å.
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downward more toward the center of the central cavity in the mLST8-CCT structure (Figure 38). We used the atomic model of the yeast CCT in the AMP-PNP conformation and the
sequences of the human CCT subunits to generate an atomic model that we subjected to flexible
docking into the 3D reconstruction of the mLST8-CCT complex using the program IMODfit
[37]. This atomic model was subsequently refined applying the real-space refinement protocol in
PHENIX [38] and Refmac5 in CCPEM. Regions where density was absent were eliminated from
the final model. This structure provides a high-resolution atomic model for human CCT (Figure
3-10b, Figure 3-7b).

Position of mLST8 in the CCT folding cavity
The most striking difference between the human mLST8-CCT structure and CCT structures from
bovine and yeast [14, 18, 32] is the presence of the mass in the interior of the cavity, positioned
between the two CCT rings and contacting both rings (asterisks in Figure 3-10). The mass has a
circular shape, indicative of a β-propeller, and docking of the atomic structure of mLST8, as
found in the mTORC1 complex [28], is very good (Figure 3-11). The quality of the fit can be
clearly seen when the mass attributable to mLST8 along with the docked mLST8 atomic
structure is extracted from the structure (Figure 3-11c). These observations suggest that the mass
corresponds to mLST8 in a stable conformation that resembles the native state. However, some
internal mass has been detected at the level of the equatorial domains in previous 3D
reconstructions of substrate-free CCT [14, 39]. Thus, to determine if the mass we observed was
indeed mLST8, we carried out a 3D reconstruction of human CCT in the absence of mLST8 and
compared the structures. For this, we isolated substrate-free human CCT from HEK-293T cells
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Figure 3-9 Comparison of yeast AMP-PNP CCT and human mLST8-CCT. A) Superimposition of yeast AMP-PNP CCT
(EMD 9541, green) and human mLST8-CCT (yellow) reconstructions. B) Angular differences between the apical domains
of the eight CCT subunits from the two structures (color coded as in panel a). Rotation angles were calculated with
Chimera using the hinge colored in red as a reference axis.
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without mLST8 over-expression (Figure 3-9a). The purified CCT was vitrified on grids and
images recorded in a Titan Krios. A total of 504,060 particles were selected and subjected to a
2D classification. The best classes (139,819 particles) were used for a 3D reconstruction, which
attained 7.5 Å resolution (Figure 3-9b). The resulting volume, albeit at a lower resolution,
shows similar structural features to that of the mLST8-CCT complex, with an open and
asymmetrical distribution in the apical domains. The major difference between the two 3D
reconstructions is the extent and shape of the mass resolved in the cavities of the CCT structure
(Figure 9c). The mass in the mLST8-CCT complex is large and accounts for the β-propeller
structure of mLST8, while that of the substrate-free CCT is much smaller and can only be
explained as part of the N- and C-terminal disordered regions of the CCT subunits known to
reside at the bottom of the folding cavity [19, 40]. This result reinforces the assignment of the
internal mass between the rings to mLST8 in the mLST8-CCT structure.
In addition to its location between the CCT rings, mLST8 is situated on one side of the
central cavity near the CCT3, 6, and 8 subunits and interacts with the disordered regions
belonging to the N- and C-terminus of several CCT subunits (Figure 3-11b). These interactions
involve the termini of CCT5, CCT7, CCT8, CCT6 and CCT3 in one of the rings, and CCT5´,
CCT7´, CCT8´, CCT6´ and to a lesser extent CCT1´ in the other ring (Figure 3-11b). Several
studies have revealed the presence of two functional hemispheres in the CCT oligomer [14, 4042], one formed by the adjacent CCT5, CCT2, CCT4 and CCT1 subunits on one side (the
CCT2hemisphere) and the other formed by CCT3, CCT6, CCT8 and CCT7 on the opposite
side (the CCT6 hemisphere). The CCT2 hemisphere shows strong ATP binding and hydrolysis
while the CCT6 hemisphere shows much weaker ATP binding and hydrolysis [43]. Collectively,
these structural observations indicate that the mLST8 molecule is bound between the two
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Figure 3-10 Position of mLST8 within the mLST8-CCT complex. A) Docking of the atomic structure of mLST8 (PDB 4JT6)
into the corresponding mass of the 3D reconstruction of the CCT-mLST8 complex. Left, sliced side view, and right, end-on
view, show how mLST8 fits in the corresponding density. B) Detailed views of the CCT subunits of each ring involved in
mLST8 interaction, showing how the unstructured N- and C-termini of several subunits contact mLST8. Left, top ring, shows
interactions with CCT5, CCT7, CCT8, CCT6 and CCT3, and right, bottom ring, with CCT5´, CCT7´, CCT8´, CCT6 ´and
CCT1´. C) The extracted cryo-EM density from between the rings with mLST8 docked shows the quality of the fit of mLST8
into this density.
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chaperonin rings on the low ATP binding side of the rings (the CCT6 hemisphere) through
interactions with the disordered termini of these subunits.

Crosslinking mass spectrometry
To further assess the location of mLST8 in the CCT folding cavity, we turned to chemical
cross-linking coupled with mass spectrometry (XL-MS), which provides distance constraints that
confirm the position of subunits within protein complexes. We treated the mLST8-CCT
complex with disuccinimyl suberate (DSS), which crosslinks adjacent lysine residues with a
maximal distance of ~ 32 Å between their Cα carbons, taking into account the length of the
lysine side chains and typical peptide backbone flexibility [44]. The crosslinked complex was
protease-digested and the resulting peptides analysed by mass spectrometry (MS). The MS data
were searched for cross-linked peptides using the pLink2 search engine [45]. The analysis
detected 196 crosslinks within and between CCT subunits, 5 crosslinks between mLST8 and
CCT subunits, and 8 crosslinks within mLST8 itself (Figure 3-12). We compared the 48
crosslinks within the conformationally stable equatorial domains to the structural model and
found that all fit the distance constraints, supporting the accuracy of the structural model and the
quality of the crosslinking data. The 5 intermolecular links involved K215 of mLST8
crosslinked to lysines in the disordered regions of the N- and C-termini of adjacent CCT subunits
(Figure 3-12a). The termini are located at the bottom of the CCT folding cavity near the
interface between the CCT rings, extending toward the center of the rings. These crosslinks are
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consistent with the position of mLST8 between the CCT rings and support the observation that
mLST8 binds to the disordered regions of the N- and C-termini of the CCT subunits.

Figure 3-11 XL-MS of the mLST8-CCT complex. A) Intermolecular crosslinks used to orient mLST8 in the cryoEM density are mapped onto the mLST8-CCT structure. Lysine residues involved in crosslinks are shown as black
spheres. B) Intramolecular mLST8 crosslinks are mapped onto the native structure of mLST8 (PDB 4JT6).

The intermolecular crosslinks were also valuable in docking mLST8 within the cryo-EM
density between the CCT rings. The circular shape of the mLST8 β-propeller allows it to fit the
density in several orientations. However, we were able to identify a preferred orientation by
minimizing crosslinking distances in the docking (Figure 3-12a). Since the links involved the
disordered termini of CCT subunits not resolved in our structural model, we used distance
constraints to the last ordered residue of the corresponding termini (CCT1 D528, CCT3 S17,
CCT4 P30 and CCT6 V13) in the analysis. The docking positioned the mLST8 β-propeller with
the K215 side facing the centre of the folding cavity.
The intramolecular mLST8 crosslinks further support the structural observation that
mLST8 has achieved a near-native structure while bound to CCT. When the eight mLST8
intralinks were mapped onto the atomic structure of mLST8 [28], all but two fell within the 32 Å
distance constraint (Figure 3-12b) when there are 10 of 28 possible crosslinks in the mLST8
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crystal structure that exceed the distance constraint. If mLST8 were less folded and highly
flexible while bound to CCT, we would have expected more crosslinks incompatible with the
crystal structure. These observations suggest that at this late stage of folding by CCT, mLST8
adopts a limited ensemble of structures that closely resembles the native state.

The nucleotide state of CCT in the mLST8-CCT complex
As described above, the mLST8-CCT complex was purified directly from cells without
adding exogenous nucleotide, so the CCT oligomer should only contain tightly bound nucleotide
that has withstood the purification process. The structure of a yeast substrate-free CCT also
purified in the absence of added nucleotide was recently reported [14]. This structure showed
that the nucleotide binding pocket was empty in five of the subunits, but was fully occupied in
CCT6 and CCT8`and partially occupied in CCT3. The authors termed this state the nucleotide
partially preloaded state (NPP). To determine the nucleotide-binding state of mLST8-CCT, we
generated a difference map of the equatorial region of the mLST8-CCT complex and that of the
AMP-PNP-bound state of yeast CCT [14], which contains nucleotide in all 16 nucleotidebinding sites (Figure 3-13). The difference map would therefore show which nucleotide-binding
sites were occupied in the mLST8-CCT complex (no electron density difference) and those that
were unoccupied (an electron density difference). Based on these differences, all the nucleotide
binding sites were empty except the two CCT8 subunits, CCT6 and partially in CCT6´ (Figure
3-13a).

This nucleotide site occupancy is similar to that of yeast except for CCT3, which was

partially occupied in yeast NPP CCT [14] and empty in human mLST8-CCT. These findings
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show that subunits with residual nucleotide binding and low ATP utilization reside on the CCT6
side of the ring, roughly the same side that binds mLST8.
Further examination of the nucleotide binding pocket of either of the CCT8 subunits
revealed electron density that is clearly attributable to ADP (Figure 3-13b). The ADP molecule
has 93 % of its solvent accessible area (566.6 Å2) buried by contacts with the interacting
residues. There are several residues that are positioned to make important hydrogen bonds (Figure
3-13b).

In addition, K171 is positioned to form a salt bridge with the β phosphate. Hydrophobic

interactions also contribute to the interaction with P49 and I497 flanking the adenine base on
either side. All of these residues are conserved among the eight human CCT subunits. Less
conserved interactions may explain why CCT6 and CCT8 release ADP more slowly than the
other subunits. D499 is unique to CCT6 and CCT8 and sits near the hydroxyl groups of the
ribose ring at close hydrogen bonding distance. In the other CCT subunits, this position is
occupied by E or Q (Figure 3-13c). The additional length of these side chains would cause steric
clashes with the ribose ring, forcing a repositioning of ADP that could decrease its binding
affinity. Furthermore, D499 is conserved in CCT6 and CCT8, supporting the idea that this
residue is important in high affinity ADP binding. Y49 is another residue unique to CCT8 that is
in position to hydrogen bond with the ribose ring oxygen. All other human CCT subunits have a
leucine at that position (Figure 13c), which is unable to form the hydrogen bond, suggesting that
Y49 also contributes to the higher affinity binding of ADP to CCT8.
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Comparison with yeast CCT
Despite the similarities in nucleotide occupancy, a comparison of the mLST8-CCT
structure with that of yeast NPP-CCT revealed a notable difference in the CCT2 apical domain.
In both structures, the chaperonin assumes an open conformation with very similar structures in
the equatorial and intermediate domains. However, in yeast NPP-CCT the intermediate and
apical domains of CCT2 adopt a Z-shaped conformation in which its helical protrusion projects
sharply outward away from the CCT folding cavity [14] (Figure 3-14). This conformation was
not observed in the mLST8-CCT structure, which shows the CCT2 apical domain tilted slightly
inward toward the center of the folding cavity like the other CCT subunits (Figure 3-14). This
conformational difference cannot be explained by the presence of substrate because the Z-shape
is not observed in substrate-free human CCT either (Figure 3-9). Moreover, a recent 8 Å
structure of bovine CCT shows a similar conformation in the CCT2 apical domain as mLST8CCT [32]. Thus, the Z-shaped conformation appears to be unique to the yeast CCT2 apical
domain.
Addition of AMP-PNP to yeast CCT changed the conformation of the CCT2 subunit to
one very similar to mLST8-CCT (Figure 3-13a), but closer inspection revealed that several of the
apical domains of mLST8-CCT were tilted more inward and downward toward the center of the
folding cavity than with yeast AMP-PNP-CCT, partially closing the folding cavity. These
differences were generally greater in those subunits interacting with mLST8 (Figure 3-13b),
suggesting that this partially closed conformational may be caused by mLST8 binding.
However, the conformational changes would have to be communicated allosterically from the
mLST8 binding site between the rings because there are no direct interactions between the CCT
apical domains and mLST8. Such long-range conformational changes are known to occur in
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Figure 3-12 Comparison of yeast apo-CCT and human CCT-mLST8. A) Superimposition of yeast NPP-CCT (EMD

9540, pink) and human mLST8-CCT (yellow) 3D reconstructions. The Z-shaped conformation of the CCT2 subunits
in the yeast CCT is marked with circles (side view) or an arrow (end-on view). B) Angular differences between the
apical domains of the eight CCT subunits from the two structures (color coded as in panel a). Rotation angles were
calculated with Chimera using the hinge colored in red as a reference axis.
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Figure 3-13 Location of the mLST8 molecule at the center of the CCT cavity. Left – The position of mLST8 (red) docked
between the CCT rings (tan) is shown, filtered to the resolution of the mLST8-CCT complex, in a cut-away side view (top) and the
two end-on views (middle and bottom). Right – Images are the same but with the mLST8 structure subtracted from the
reconstruction, showing the small amount of remaining mass surrounding the mLST8 molecule.
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CCT when ATP hydrolysis in the equatorial domains results in changes in the apical domains
that close the folding cavity [21].

Discussion
The findings reported here provide evidence that the cytosolic chaperonin CCT
contributes to mTOR complex assembly and mTOR signaling by folding the β-propellers of
mLST8 and Raptor, affording a possible explanation for the genetic links between CCT and
yeast TOR observed previously [8-10]. The high-resolution structure of the mLST8-CCT
complex provides insight into how mLST8 folding may occur. The mLST8 has achieved a nearnative state while bound to CCT, suggesting that the complex represents a late folding
intermediate that is ready to bind mTOR upon release from CCT. The position of mLST8 deep
in the CCT structure between the rings is surprising because this region has not previously been
implicated in substrate binding. Most studies of both type I and type II chaperonins have
identified substrate binding sites in the apical domains far from the N- and C-termini in each ring
[13, 32, 46-49]. These termini are all located at the bottom of the folding cavity and have been
proposed to create a barrier that separates the two folding cavities [19, 40]. However, the
mLST8-CCT structure shows that the folding cavities are not separated and that CCT can bind
substrates between the rings via interactions with the N- and C-termini. This observation is
consistent with other biochemical and structural studies suggesting that the termini can
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participate in substrate interactions for both type I [50-52] and type II [27] chaperonins. These

Figure 3-14 The role of CCT in the folding of β-propeller proteins. A) Differences in the β-propeller location in the CCT cavity. The 3D
reconstructions of Gβ-CCT (white)[1] and mLST8-CCT (brown) reveal the different location of the two β-propellers. B) Position of the mTOR
binding site on mLST8 in the mLST8-CCT complex. Residues on mLST8 that bind mTOR are shown as yellow spheres. C) Hypothetical scheme
of the chaperones involved in assembly of mTOR complexes, highlighting CCT-dependent folding of mLST8 and Raptor.
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interactions appear to involve specific substrates and/or late stage intermediates in the folding
process.
A closer look at the mLST8-CCT reconstruction reveals several thin masses that extend
from the equatorial domains of CCT5, CCT7, CCT8, CCT6 and CCT3 in one ring and CCT5´,
CCT7´, CCT8´, CCT6´ and CCT1´ in the other ring to suspend mLST8 between the rings
(Figure 3-11b). These masses likely correspond to the N- and C- termini of the subunits because
they are known to extend into the space between the rings [31, 40] and several of the termini
crosslink to mLST8 (Figure 3-12a). The disordered nature of these regions does not allow a
more detailed description of the interactions, but a difference map between the mLST8-CCT
reconstruction and the structure of native mLST8 docked into the mass between the rings shows
extra mass, attributable to the termini, that surrounds the bound mLST8 at specific points (Figure
3-15). These observations suggest that CCT contacts mLST8 almost exclusively through the
termini of the subunits.
CCT is known to fold the β-propellers of other proteins, including G protein β subunits.
A previous, low-resolution cryo-EM structure of the Gβ1-CCT complex, also purified directly
from cells [1], shows that despite its close structural homology to mLST8, Gβ1 interacts with
CCT in the apical domains where other CCT substrates have been shown to bind (Figure 3-16a).
A question that arises from these observations is how CCT interacts so differently with
structurally homologous β-propellers like Gβ and mLST8. The answer may lie in the N-terminal
α-helix of Gβ, not found in mLST8, which makes a coiled-coil interaction with the G protein γ
subunit in the Gβγ dimer. This helix contacts the apical domain of CCT3 and holds Gβ high in
the CCT folding cavity where it can interact with PhLP1, the CCT co-chaperone that releases Gβ
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from CCT to form the Gβγ dimer [1]. In contrast, PhLP1 does not assist in mLST8 folding or
release (Figure 3-5), probably because PhLP1 cannot access mLST8 between the CCT rings
from its binding site at the top of the CCT apical domains. In contrast, ATP binding and
hydrolysis contribute to release of mLST8 from its position between the rings (Figure 3-1g),
suggesting that the conformational changes in CCT upon ATP hydrolysis dislodge mLST8 to
interact with mTOR. Interestingly, the mTOR binding site on mLST8 is exposed in the interior
of the CCT folding cavity (Figure 3-16b), suggesting that the mTOR kinase domain could
interact with mLST8 while still bound to CCT.
In the mLST8-CCT structure, mLST8 is located on the CCT3 hemisphere of the ring
(Figure 3-11a), associating principally with CCT5, CCT7, CCT8 and CCT6. Gβ also associates
with the CCT6 side, despite binding to the apical domains [1]. Interestingly, the CCT6 and
CCT8 subunits on this same side of the ring retain their nucleotide throughout the tandem
affinity purification. This slow release from the CCT6 hemisphere explains previous
observations that showed poor ATP binding on the CCT6 side [43]. An asymmetric ATPbinding and sequential substrate folding mechanism for CCT was previously proposed in which
bound substrates are first released from the CCT2 hemisphere, because of efficient ATP binding
and hydrolysis on the CCT2 side, and are then retained on the CCT6 hemisphere because of low
ATP utilization [43, 53]. The positions of mLST8 and Gβ in folded β-propeller structures on the
CCT6 side is consistent with this sequential folding mechanism. It is possible that sequential
release of β-propeller proteins may facilitate their complex folding trajectory, which requires that
the N- and C-termini come together to form the last blade of the β-propeller.
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These results reveal an important function for CCT in the folding of mLST8 and Raptor
in preparation for their assembly into mTOR complexes. Based on our findings and other studies
on protein folding by CCT, we propose a hypothetical scheme for the assembly of mTOR
complexes (Figure 3-16c). The β-propeller domains of nascent mLST8 and Raptor likely bind to
CCT in a partially folded state either co-translationally or soon thereafter [13]. They are then
folded by CCT into their β-propeller structures through cycles of ATP binding and hydrolysis
and are released to interact with nascent mTOR and create the mTORC1 complex, while mTOR
itself is folded by the Hsp90 TTT-R2TP co-chaperone complex [6, 7]. In the case of mTORC2,
mLST8 and mTOR are folded by the same mechanism, but it is currently not known how the
other core components, Rictor and mSIN1, are folded before assembly. There are a number of
questions yet to be answered in mTORC assembly, but this study establishes a key role for CCT
in the process. These contributions of CCT to mTORC assembly may underlie the diseases
caused by inactivating CCT mutations [54] or the increased CCT activity in cancer cells [55],
given the essential functions of mTOR in regulating cell metabolism, growth and survival.

Methods
Cell Culture
Human embryonic kidney (HEK)-293T cells (ATCC) were grown in 10% fetal bovine
serum (FBS) in DMEM/F12 media, and HepG2 liver hepatocellular carcinoma cells (ATCC)
were grown in DMEM media. Cells were passaged to maintain confluency between 10-90% and
passage number was kept under 15.
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CRISPR knockdown
Knockdowns were done using the PX459 V2.0 vector (Addgene) containing sgRNAs
targeting CCTε, Raptor or PhLP1. The same vector with a non-targeting sgRNA segment was
used as a negative control. These vectors were transfected into HEK-293T cells at 25-40%
confluency with Lipofectamine 3000 (Thermo Fisher Scientific) and then treated with 1 μg/mL
puromycin (Invivogen). 48 hours after transfection of PX459V2.0, cells were transfected with
vectors containing mTORC or Gβγ components. Cells were harvested for immunoprecipitation
and immunoblotting 96 hours after addition of the sgRNA vector.

Immunoprecipitation
HEK-293T cells were cultured and transfected in six-well plates. Cells were washed in
PBS and lysed in 200 µL of PBS supplemented with either 1 % IGEPAL (for mTORC1 and
Gβγ) or 0.3-0.5 % CHAPS (for CCT and mTORC2), 0.5 mM PMSF and Halt Protease Inhibitor
Cocktail (Sigma P8340). Protein concentrations were determined using the DC protein assay
(BioRad 5000116) and equal protein amounts (~ 400 µg) were immunoprecipitated by addition
of epitope tag antibodies, followed by 30 µL of protein A/G agarose beads (Santa Cruz).
Immunoprecipitants were washed three times in lysis buffer, then resuspended in SDS-PAGE
loading buffer. Proteins were separated by SDS-PAGE and transferred to nitrocellulose (Biorad
Transblot). The nitrocellulose was probed with the indicated primary antibodies and IRDye
secondary antibodies (Li-COR). Blots were imaged using a LI-COR Odyssey infrared scanner,
and proteins were quantified with the LI-COR software.
The effects of ATP on the co-immunoprecipitation of mLST8 and Raptor with CCT was
performed in a cell line expressing a Flag-tagged CCT3 subunit. To insert the Flag tag, we
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transfected HEK293T cells with Cas9 and sgRNA targeting CCT3 (Addgene px458 vector)
along with a double stranded DNA fragment for a donor template containing a Flag tag to be
inserted in an external loop between P374 and K375 (synthesized G block by Integrated DNA
Technologies). Cells were sorted into 96-well plates and monoclonal lines were screened via
immunoblotting for a Flag-tagged CCT3. The cell line was verified by PCR and sequencing.
These cells were transfected with either mLST8 or Raptor. We then performed an
immunoprecipitation as described above using Flag antibody. After two washes in lysis buffer
containing 0.5 % CHAPS, samples were incubated at 4°C in this buffer for an additional three
hours during which 5 mM ATP was added after 0, 1 or 2 hrs so that samples were incubated in
ATP for a total of 1, 2 or 3 hrs. The zero sample was incubated without ATP for 3 hrs.
Following the incubation, samples were washed two more times and then immunoblotted as
previously described.

Insulin signaling
HepG2 cells were chosen for these experiments because of their robust response to
insulin. Cells were treated with 40 nM of siRNA targeting CCTα/ε, mLST8 or Raptor or a nontargeting control using Lipofectamine 3000. 72 hours after knockdown, cells were serum starved
for 18 hours. Subsequently, the cells were treated with 100 nM insulin for 30 minutes and the
lysates were harvested in 1% IGEPAL in HEPES buffer supplemented with 0.5 mM PMSF, Halt
Protease Inhibitor Cocktail and phosphatase inhibitor (Thermo Fisher). The effects on mTORC1
and mTORC2 signaling were analyzed by immunoblotting the cell lysates for phosphorylation at
IRS1 S636/639 and AKT S473, respectively. Total CCT, mLST8, Raptor, AKT and IRS1 were
also immunoblotted to assess the respective knockdown and expression level.
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qPCR
HEK-293T cells were depleted of CCT using CRISPR as described above and were
harvested for RNA isolation (Zymo RNA isolation kit) 96 hours later. Qiagen one-step RT PCR
kit was used for the reverse transcription step. The qPCR was done using IDT PrimeTime assays
with predesigned primers for mTOR, Raptor, mLST8 and HPRT as a control. Real Time PCR
was performed using the QuantStudio 5 Real Time PCR system and data were analyzed using
the QuantStudio Design and Analysis software.

Statistical Analysis
The statistical analysis was performed using the BootstRatio, a web-based statistical
analysis program which calculates probability that the relative expression, RE ≠1 [56].
BootstRatio allows calculation of statistical significance when data is normalized to a control
sample. The application can be found at: http://regstattools.net/br.

Isolation of mLST8-CCT
HEK-293T cells were cultured as described above in T-175 flasks. At 80% confluency,
each flask was transfected with 45 μg N-terminal HPC4-Twin Strep-Flag-mLST8 in pcS2+
vector and with 45 μg His6-myc-PhLP1 in pcDNA3.1B+ using 200 μg of polyethylenimine
(PEI). The media was replenished with DMEM/F12 after 2-4 hours, and the cells were
incubated for 48 additional hours before harvesting. Cells from each T175 were lysed in 2 mL of
extraction buffer 1% IGEPAL in PBS with 0.5 mM PMSF and Halt Protease Inhibitor Cocktail.
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The lysate was cleared by centrifugation at 30,000 x g for 20 minutes. The lysate was then
filtered through a 0.45 μm and then a 0.2 μm filter.
The mLST8-CCT complex was purified at 4° C by tandem affinity purification (TAP).
The filtered lysate was loaded for 1 hour onto a HisTrap HP 5 mL column (GE17-5248-01)
equilibrated with 20 mM HEPES, 20 mM NaCl, 25 mM imidazole, 0.05% CHAPS, 1 mM
TCEP, pH 7.5. The column was washed with 5 column volumes of equilibration buffer. A
linear gradient from 25 mM to 500 mM imidazole was then applied over 8 column volumes.
Elution fractions were then analyzed by SDS-PAGE and Coomassie staining. Fractions
containing mLST8 and CCT were combined and loaded for 1 hour onto 5 mL of Strep-Tactin
resin (Iba 2-1201-010) equilibrated with 20 mM HEPES pH 7.5, 20 mM NaCl. The column was
washed twice with one column volume of 20 mM HEPES pH 7.5, 150 mM NaCl, 0.05%
CHAPS, and then twice with one column volume of 20 mM HEPES pH 7.5, 20 mM NaCl,
0.05% CHAPS. The mLST8-CCT complex was eluted with 3 column volumes of 20 mM
HEPES pH 8.0, 20 mM NaCl, 0.05% CHAPS, 2.5 mM D-desthiobiotin and concentrated to 1
μg/μL using a 30 kDa cutoff filter (Amicon UFC803024) and analyzed by SDS-PAGE and
Coomassie staining and immunoblotting. The sample was then flash frozen in liquid nitrogen.

Isolation of substrate-free CCT
HEK-293T cells were cultured in T-175 flasks as described above. At 80% confluency,
each T175 flask was transfected with 90 μg of His6-myc-PhLP1 in pcDNA3.1B+ using 200 μg of
polyethylenimine (PEI). The cells were then lysed and loaded onto a HisTrap column as
described for mLST8-CCT. The combined HisTrap elution fractions were then loaded for half
an hour onto a HiTrap Heparin HP 5 mL column (GE17-0406-01) equilibrated with 20 mM Tris95

HCl pH 7.5, 150 mM NaCl, 2.5 mM MgCl2, 1 mM TCEP. The column was washed with 2
column volumes of equilibration buffer. A linear gradient from 150 mM to 1 M NaCl was then
applied over 8 column volumes. Elution fractions were then analyzed by SDS-PAGE and
Coomassie staining, and fractions containing CCT were combined and concentrated in a 30 kDa
cutoff filter (Amicon UFC803024) to less than 300 μL. The sample was then injected onto a
Superose 6 10/300 GL size exclusion column (SEC) equilibrated in 20 mM HEPES pH 7.5, 150
mM NaCl, 1 mM TCEP mobile phase. One column volume of mobile phase was then run over
the column and fractions were analyzed by SDS-PAGE and Coomassie staining. The sample
was concentrated to 1 μg/μL using a 30 kDa cutoff filter and flash frozen in liquid nitrogen.

Crosslinking
Approximately 200 μg of mLST8-CCT complex was crosslinked in 25 mM HEPES pH
8.0, 100 mM KCl, and 325 μM of a 50 % mixture of H12/D12 disuccinimidyl suberate (DSS)
(Creative Molecules) at 37°C for half an hour. The reaction was quenched by adding 50 mM
ammonium bicarbonate to the crosslinked sample and incubating at 37°C for 15 minutes. The
sample was dried using a vacuum concentrator, denatured in 100 mM Tris-HCl pH 8.5 and 8 M
urea, reduced with 5 mM TCEP at 37°C for 30 minutes, and alkylated with 10 mM
iodoacetamide at room temperature in the dark for 30 minutes. The sample was diluted with 150
mM ammonium bicarbonate to bring the urea concentration to 4 M, and proteins were digested
with 4 μg of lysyl endopeptidase (Wako 125-05061) (1:50 enzyme: substrate ratio) at 37°C for
two hours. Subsequently, the urea was diluted to 1 M, and proteins were further digested with
trypsin (Promega V5111) at a 1:50 ratio at 37°C overnight. Peptide fragments were purified on a
C18 column (Waters WAT054955), dried, and reconstituted in 35 μL SEC mobile phase
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(70:30:0.1 water:acetonitrile:TFA). Crosslinked peptide fragments were enriched by SEC using
a Superdex Peptide PC 3.2/30 column at a flow rate of 50 μL/min. The fractions with the highest
peptide concentration were dried and resuspended in 2% formic acid.

Mass spectrometry
The enriched crosslinked peptide samples were separated using a Thermo Fisher
Scientific EASY-nLC 1000 Liquid Chromatograph system with a 15 cm Picofrit column (New
Objective) packed with Reprosil-Pur C18-AQ of 3 μm particle size, 120 Å pore size and gradient
of 5-95% acetonitrile in 5% DMSO and 0.1% formic acid over 185 minutes and at a flow rate of
350 μL/min. The column was coupled via electrospray to an Orbitrap Velos Pro mass
spectrometer. The resolution of MS1 was 30,000 over a scan range of 380-2000 m/z. Peptides
with a charge state +3 and greater were selected for HCD fragmentation at a normalized collision
energy of 35% with 3 steps of 10% (stepped NEC) and a resolution of 7,500. Dynamic
exclusion was enabled with a 10 ppm mass window and a one-minute time frame. Samples were
run in duplicate.

XL-MS analysis
The XL-MS spectra were analyzed using the pLink 2 software suite [45]. First, the
peptide sequence database was created from the amino acid sequence of human mLST8 and the
eight human CCT subunits (UniProt ID: Q9BVC4, P17987, P78371, GenBank: CAA52808.1,
P50991, P48643, P40227, Q99832, P50990 respectively). The sequences of 293 common
contaminant proteins were also added by pLink. The program was then run using the preset DSS
conventional crosslinking (HCD) conditions and a custom heavy DSS linker profile
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(LinkerComposition: C(5)H(-2)2H(6)O(2), MonoComposition: C(5)H(6)O(3), LinkerMass:
102.064, MonoMass: 120.075), with trypsin set as the protease and up to 3 missed cleavages
allowed. Peptides were selected with a mass between 600 and 6,000 Da and a length between 6
and 60 amino acids. The precursor and fragment tolerances were ± 20 ppm. The peptides were
searched using carbamidomethyl C) fixed modifications and phospho Y, T, S and oxidated M
variable modifications. The results were filtered with a filter tolerance of ± 10 ppm and less than
5% FDR.

Cryo-EM grid preparation and data acquisition
Cryo-EM grids were prepared with a Vitrobot Mark IV (FEI) at 22 ºC and 95% humidity.
Aliquots of 4 μl of human CCT-mLST8 complex or apo-CCT were applied to a glow discharged
holey carbon grid (Quantifoil R2/2, 300 mesh). Grids were previously treated with polylysine to
increase the number of side views of the chaperonin, as previously described [14]. The mLST8CCT data acquisition was performed at ESRF Grenoble with a FEI Titan Krios electron
microscope (Krios 1) operating at 300 kV, equipped with a Gatan K2 Summit direct electron
detector mounted on a Gatan Bioquatum LS/967 energy filter. Data collection was carried out
with a nominal magnification of 105,000× (yielding a pixel size of 1.36 Å/pixel), at a defocus
range of −1.5 to −3.0 μm. A total of 5576 movies were recorded and fractionated to 40 frames
with a total exposure of 7 s. The dose rate was 5.2 e-/pixel/s for a total dose of 36 e−/Å2 on the
specimen.
Substrate-free CCT grids were prepared as described above and images were collected on
a FEI Titan Krios electron microscope operating at 300 kV at Diamond Light Source (DLS)
electron Bio-Imaging Centre (eBIC) (Krios 1), at a nominal magnification of 130,000×
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(corresponding to a pixel size of 1.06 Å/pixel). A total of 2293 movies (40 frames/movie) were
recorded on a Gatan Quantum K2 Summit direct electron detector operated in counting mode,
with a defocus range of −1.5 to −3.0 μm. Each movie was exposed for 8 s, with an exposure rate
of 5.3 e-/pixel/s, leading to a total accumulated dose of 42 e−/Å2 on the specimen.

Image processing
The 5576 movies of mLST8-CCT complex were aligned using MotionCorr2 [57]
program as part of the Scipion processing workflow [58]. The MotionCorr2 output was
subjected to CTF determination using CTFFIND4 [59]. 1,769,600 particles were automatically
picked with Xmipp [60] and extracted with a downsampling factor of 3 (4.08 Å/pixel, 68 pixel
box size). All the image processing steps were carried out without any symmetry imposition. A
first 2D classification using Relion 2.0 [61] (unless otherwise stated Relion 2.0 was used in all
subsequent steps) was performed to exclude bad particles and ice contamination. Some of the
best 2D classes were used as a template to generate an initial model using both EMAN [62] and
RANSAC [63]. In both cases a cylinder with the general dimensions similar to the CCT structure
was obtained, which was subsequently used for the iteration process. One of the models was
low-pass filtered to 60 Å and used for a 3D classification of 1,197,358 particles contained in the
best 2D classes. The 3D classes that showed well-defined CCT features and a mass inside the
cavity (860,453 particles) were subjected to refinement using 3D auto-refine, which generated a
9 Å map. The particles used in this refinement were re-extracted from the 1.36 Å/pixel
micrograph to continue the processing with the original data. A new 3D classification was
performed in which a mask was applied around the mass attributed to the substrate in order to
favor the classification to the substrate contribution and prevent the CCT predominance. Those
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particles with a better-defined mLST8 mass (452,000) were finally subjected to auto-refine and a
map was obtained with a final resolution of 4.35 Å. Subsequently, a postprocessing was
performed masking the previous map and enhancing the high frequencies and the resolution
improved to 4.0 Å, as estimated using the gold standard FSC criterion at 0.143 [64]. Local
resolution in the 3D structure of the mLST8-CCT complex was estimated using MonoRes [65]
from Xmipp package and ResMap [66].
The 3D reconstruction of substrate-free CCT was carried out following a similar
procedure. A total of 2293 movies were aligned with MotionCor2 and CTF corrected. A total of
504,060 particles were automatically selected and extracted with a downsampling factor of 3
(3.18 Å/pixel, 80 pixel box size). Particles were 2D classified using Relion 2.0 and the best
classes (139,819 particles) were subjected to 3D classification. Classes with the best structural
features of CCT were further refined, the particles were re-extracted from the original
micrographs (1.06 Å/pixel) and after 3D refinement, a final map at 7.5 Å was obtained (gold
standard FSC).

Model building
Models for each human CCT chain were generated using SWISS-MODEL homologymodelling server [67] using the yeast CCT structure (PDB 5GW5) as a reference. The resulting
model was docked into the cryo-EM density using Chimera [68] and further subjected to flexible
fitting of the individual subunits with iMODFIT [37]. Manual adjustment and real-space
refinement were carried out in COOT [69] to increase the quality of the fitting. The resulting
model was refined by several rounds using PHENIX [38] and CCP-EM [70] software suites.
The restraints used in phenix real-space refinement were both the standard (bond, angle,
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planarity, chirality, dihedral and nonbonded repulsion), with some additional restraints
(Ramachandran plot, C-beta deviations, rotamer and secondary structure). A local grid searchbased fit was included in the refinement strategy to resolve side-chain outliers (rotamers or poor
map fitting). Validation of the final model was done using the phenix.validation_cryoem module
in PHENIX.

Nucleotide distribution analysis
In order to detect and identify nucleotides in the CCT subunits, the equatorial domain of
yeast CCT ATP-BeF2 (PDB 4D8R) was docked into the human CCT-mLST8 model and the
yeast CCT AMP-PNP model (PDB 5GW5) in order to segment the equatorial domains. A
difference map between them was generated using the vop subtract operation implemented in
Chimera. A detailed inspection of the nucleotide binding pocket of all the CCT subunits of
mLST8-CCT showed a clear difference between nucleotide-free and nucleotide-bound subunits
and allowed the modelling of an ADP molecule in CCT8. The NCBI Blastp web-based suite
was used to perform an alignment of the eight human CCT subunits (Uniprot ID: P17987,
P78371, P49368, P50991, P48643, P40227, Q99832, P50990) as well as yeast, drosophila,
murine, and bovine CCT6 (Uniprot ID: P39079, Q9VXQ5, P80317, Q3MHL7) and CCT8
(Uniprot ID: P47079, Q7K3J0, P42932, Q3ZCI9) to identify conserved and unique residues in
the ADP binding site.
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Abstract
Bardet–Biedl syndrome (BBS) is a genetic disorder characterized by malfunctions in
primary cilia resulting from mutations that disrupt the function of the BBSome, an eight-subunit
complex that plays an important role in protein transport in primary cilia. To better understand
the molecular basis of BBS, here we used an integrative structural modeling approach consisting
of EM and chemical crosslinking coupled with MS analyses, to analyze the structure of a
BBSome 2-7-9 subcomplex consisting of three homologous BBS proteins, BBS2, BBS7, and
BBS9. The resulting molecular model revealed an overall structure that resembles a flattened
triangle. We found that within this structure, BBS2 and BBS7 form a tight dimer through a
coiled-coil interaction and that BBS9 associates with the dimer via an interaction with the α107

helical domain of BBS2. Interestingly, a BBS-associated mutation of BBS2 (R632P) is located in
its α-helical domain at the interface between BBS2 and BBS9, and binding experiments
indicated that this mutation disrupts the BBS2–BBS9 interaction. This finding suggests that
BBSome assembly is disrupted by the R632P substitution, providing molecular insights that may
explain the etiology of BBS in individuals harboring this mutation.

Introduction
Primary cilia perform vital signaling functions in vertebrate cells, ranging from
recognition of developmental cues from morphogens such as hedgehog in the developing embryo
to detection of sensory signals such as photons of light in retinal photoreceptor cells (1-4).
Primary cilia are formed by the axoneme, a circularly-ordered scaffold containing nine pairs of
microtubules anchored inside the cell at the basal body and protruding outward to create a fingerlike projection of the plasma membrane (1,2). Many transmembrane receptors are concentrated
in this ciliary compartment, creating a type of signaling antenna for the cell (5-7). The contents
of the cilium are delivered there by the intraflagellar transport (IFT) complexes that use kinesin
motors to move cargos toward the tip of the cilium (anterograde transport) and dynein motors to
move cargos toward the base of the cilium (retrograde transport) (1,2,4). Failure of ciliary
trafficking results in diseases referred to as ciliopathies that are characterized by multiple
phenotypes, including cystic kidneys, retinal degeneration, obesity and multiple developmental
disorders (8).
One of these ciliopathies is Bardet-Biedl syndrome (BBS), a disease that results from the
malfunction of a large protein complex called the BBSome (9). The BBSome consists of eight
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subunits (named BBS1, 2, 4, 5, 7, 8, 9 and 18), and mutations in each subunit have been linked to
BBS (9-12). The disease results from an inability of the BBSome to participate in ciliary
transport. The proposed function of the BBSome is to act as a scaffolding complex to link
protein cargos, including membrane proteins, to the IFT machinery for ciliary transport with a
particularly important role in retrograde transport out of the cilium (11,13-18). The BBSome
reversibly associates with the membrane via an interaction of BBS1 with ARL6 (ADPribosylation factor-like protein 6), a small GTPase that interacts with the membrane in its GTPbound form (11,19). In this membrane-bound state, the BBSome is believed to pick up
membrane proteins targeted for exit from the cilium (11,18). Transport of these cargos occurs
through association of the BBSome with the IFT-B complex via an interaction with a linker
protein LZTFL1 (Leucine zipper transcription factor-like 1) that binds to IFT27 in the IFT-B
complex (15,16,20). In this manner, the BBSome collects membrane proteins for IFT- and
dynein-mediated retrograde transport.
To perform its transport function, each of the eight subunits of the BBSome must be
translated on ribosomes, folded into their native state and assembled into a functional complex.
Evidence suggests that BBSome assembly proceeds through several subcomplexes, with BBS9
acting as a central scaffold. A stable hexameric complex consisting of human BBS1, 4, 5, 8, 9
and 18 was recently isolated from insect cells (21). This subcomplex interacted with Arl6 as well
as peptide motifs from several G protein-coupled receptor cargos. The two other subunits of the
BBSome, BBS2 and BBS7, have an intricate folding and assembly process that requires a
network of molecular chaperones, including the cytosolic chaperonin containing tailless
polypeptide 1 (CCT; also termed TRiC) complex and three chaperonin-like proteins named
BBS6, 10 and 12 (22,23). Inactivating mutations in these chaperonin-like BBS proteins are also a
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major cause of BBS (24-26). The chaperonin proteins associate with BBS2 and BBS7 and assist
in the formation of a BBS2/BBS7 dimer that binds BBS9 via an interaction with BBS2 (23,27).
Presumably, binding of the BBS2/BBS7 dimer with the hexameric complex completes the
assembly of the BBSome octamer (21).
To better understand the mechanism of BBSome assembly, its function as a scaffold for
intraflagellar transport and the molecular basis of BBS disease, we have isolated a trimeric
BBSome subcomplex of BBS2, BBS7 and BBS9 and investigated its structure by electron
microscopy (EM) and chemical crosslinking coupled with mass spectrometry (XL-MS) using the
integrative modeling platform (28). The data show that the BBS2/BBS7 dimer is stabilized by an
extensive coiled-coil interaction and that BBS9 interacts with the dimer through association with
the α-helical domain of BBS2. A BBS-causing mutation in BBS2 (R632P) (29-31) in this region
disrupts the interaction of BBS2 with BBS9, suggesting that the inability of the BBS2/BBS7
dimer to associate with the hexameric complex is the underlying cause of BBS in patients with
the R632P mutation.

Results
BBS2-7-9 purification
The subcomplex between BBS2, BBS7 and BBS9 is an important early intermediate in
assembly of the BBSome (23). We purified this BBS2-7-9 subcomplex for structural studies by
co-expressing affinity-tagged versions of each subunit in HEK-293T cells and isolating
complexes containing the Strep peptide-tagged BBS7 using a Strep-Tactin column. This
purification resulted in roughly equal amounts of BBS2, BBS7, BBS9 with a 70 kDa
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Figure 4-1 Purification of the BBS2-7-9 Complex and 3D EM reconstruction A) Left. Coomassie-stained SDS gel
of the BBS2-7-9 complex purified by Strep-Tactin affinity purification. Flag-tagged human BBS9 (99.3 kDa)
migrated below the 120 kDa molecular weight standard, and Strep-tagged human BBS7 (80.4 kDa) and HPC4tagged human BBS2 (79.9 kDa) migrated near the 90 kDa molecular weight standard. The identity of these protein
bands was confirmed by immunoblotting (right). B) Silver-stained SDS gel of the BBS2-7-9 complex purified as in
panel A and separated by a glycerol gradient. The post-centrifugation fractions were loaded from the top (left) to
the bottom (right). The fractions with a blue line (fraction numbers 10-13) were used for EM analysis. C) A
representative image of a negatively-stained field of BBS2-7-9 complex with the particles circled (bar = 500 Å). D)
A sampling of the 2D class averages used in the reconstruction. E) Three orthogonal images of the 3D
reconstruction of the BBS2-7-9 complex. (bar = 100 Å).
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contaminant protein corresponding to heat shock protein 70 (Hsp70) isoforms (Figure 4-1A).
The complex was further purified by glycerol gradient centrifugation (Figure 4-1B), which
separated Hsp70 and other contaminants (fractions 3-9 and 15-25) from the subcomplex
(fractions 10-13).

3D reconstruction of BBS2-7-9
We assessed the homogeneity of the complex by negative stain EM and found that
despite the purity of the preparation, the particles were not sufficiently homogeneous for a highresolution structural analysis by cryo- electron microscopy (Figure 4-1C, D). As a result, we
carried out a low-resolution 3D reconstruction using negative-stained EM images. The
reconstruction (23 Å resolution) revealed the overall structure of the complex (Figure 4-1E),
which can be described as a flattened, triangular structure with a ~ 200 Å height and ~ 120 Å
width at the base, with a small mass ~ 40 Å in diameter protruding from one of the sides.

XL-MS analysis of BBS2-7-9
In the absence of high-resolution cryo-EM data, we used the low-resolution EM envelope
combined with cross-link mass spectrometry (XL-MS) to generate a molecular model of the
BBS2-7-9 complex. XL-MS has become an effective tool to probe the structural architecture of
protein complexes (32,33). The crosslinks identified by XL-MS provide distance constraints that
can be combined with EM reconstructions and other structural information to define the
structures of protein complexes (34-39) (Figure 4-3A). We treated the purified sample with
increasing amounts of the crosslinker to determine the optimal concentration of crosslinker to
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use (Figure 4-2). Ultimately, the purified BBS2-7-9 was crosslinked with three different lysinespecific crosslinkers, disuccinimidyl suberate (DSS), disuccinimidyl glutarate (DSG) or Leiker
reagent (40) and digested with proteases. The digests were analyzed by LC-MSMS, and
crosslinked peptides were identified using the crosslink search engines xQuest (41) and pLink
(42). Only high confidence hits that satisfied the screening criteria (see Experimental
Procedures) were considered as true crosslinks. The coverage was nearly complete with 86 %
(BBS2), 90 % (BBS7) and 87 % (BBS9) of all lysine residues reacting with the crosslinking
reagents. Of those, 68 % (BBS2), 66 % (BBS7) and 78 % (BBS9) were involved in crosslinks
while the rest formed monolinks.

Figure 4-2 Titration with DSS crosslinker. Coomassie-stained SDS gel of a titration of BBS2-7-9 complex treated with
increasing amounts of DSS crosslinker. Bands at the top of the gel are multimeric crosslinked sample and lower bands are
monomeric BBS2-7-9 subunits

Domain modeling
XL-MS generates three types of crosslinks that provide different structural information:
crosslinks within individual domains of the BBSome subunits (intra-domain crosslinks),
crosslinks between domains of the subunits (inter-domain crosslinks) and crosslinks between
subunits (inter-protein crosslinks). The XL-MS analysis identified 51 intra-domain crosslinks
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(Figure 4-3). These crosslinks were used to validate structural models of the individual domains
of the core subunits. BBS2, 7 and 9 are homologous proteins that share a well-defined domain
organization with N-terminal β-propeller, followed by coiled-coil, γ-adaptin ear (GAE),
platform, and C-terminal α-helical domains (11). One atomic structure of the β-propeller domain
of BBS9 has recently been reported (43), and the structures of homologous domains in other
proteins have been solved (11,19). Given these homologs, we reasoned that accurate structural
models of each domain could be determined, and we generated homology models of each
domain using the protein structure prediction server I-TASSER (44) (Figure 4-3B). The
percentage of sequence modeled in these domains for BBS2, BBS7 and BBS9 was 95 %, 96 %
and 96 %, respectively.
To assess the accuracy of the domain models, we mapped a list of all the theoretical
lysine pair crosslinks onto the domain models and calculated Cα-Cα distances between the lysine
residues. Considering movement of the protein backbone in flexible regions, the distance
constraints were < 35 Å for DSS, < 31 Å for the DSG and < 33 Å for Leiker (36). We found that
21 % of all possible crosslinks in the domain models exceeded the 35 Å DSS distance constraint.
Yet when we mapped the experimentally determined intra-domain crosslink distances on the
model structures, only one DSG crosslink of the 51 intra-domain crosslinks fell outside the
distance constraints (Figure 4-3C). This consistency between the structural models and the
crosslinking distances validates the accuracy of the domain models for BBS2, 7 and 9 and the
quality of the crosslinking data. These domain models were used as building blocks to assemble
the BBS2-7-9 structure.
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Figure 4-3 Domain structural models of the components of the BBS2-7-9 complex. A, workflow for the XL-MS
experiments. The purified BBS2-7-9 complex was cross-linked and digested with proteases. Cross-linked peptides were
enriched and analyzed by LC-MS/MS. Cross-links were identified using the xQuest and pLink search engines. B, models of
the domains of BBS2-7-9 complex components were created in I-TASSER except for the BBS9 β-propeller domain, which
was from an X-ray crystal structure (PDB 4YD8). 115
Intra-domain cross-links were mapped onto the structures. C, euclidean
Cα distance distribution of the lysine cross-links based on the domain structural models. All but one cross-link (orange bar)
fit inside the expected distance constraints of 35 Å for DSS, 31 Å for DSG, and 33 Å for Leiker.

BBS2 and BBS7 coiled-coil interaction
XL-MS identified 22 inter-protein crosslinks which were used to locate sites of
interaction between subunits of BBS2-7-9 (Figure 4-4A). Sixteen of the crosslinks were between
BBS2 and BBS7 and six of these were in regions predicted to form a coiled-coil (residues 334363 of BBS2 and 339-376 of BBS7). This high density of crosslinks supports the idea that BBS2
and BBS7 associate via a coiled-coil interaction in these regions. To determine if the coiled-coil
interaction was parallel or anti-parallel, we modeled the coiled-coil region to both parallel and
anti-parallel templates using the Foldit program (45) (Figure 4-5). When the cross-linking
constraints were included in the modeling, the parallel template produced a compact coiled-coil
structure with cross-link distances between 12-15 Å (Figure 4-4B). In contrast, applying the
cross-link constraints converted the anti-parallel template model into a parallel one,
demonstrating that the cross-links were only compatible with a parallel model. The parallel
model predicted that residues 334-363 of BBS2 participated in the coiled-coil with residues 339363 of BBS7 and that residues 364-376 of BBS7 were not part of the coiled-coil (Figure 4-4B).
The interface between the two helices was populated by hydrophobic residues as expected for a
coiled-coil interaction (Figure 4-4C). Interestingly, no inter-protein crosslinks were found in the
same coiled-coil region of BBS9, indicating that BBS9 does not form a coiled-coil interaction
with BBS2 or BBS7. These data are consistent with pair-wise co-immunoprecipitation
experiments that showed interactions between BBS2 and BBS7 as well as between BBS2 and
BBS9 but not between BBS7 and BBS9 (23,27).
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Figure 4-4 Coiled-coil interaction between BBS2 and BBS7. A) BBS2-7-9 complex inter-protein cross-links determined by
XL-MS. Six of these interlinks were found between the coiled-coil regions of BBS2 and BBS7. B) structural model of the
coiled-coil interaction between BBS2 and BBS7 with cross-links mapped onto the model. The table lists the Euclidean Cα
distances of the cross-linked lysines. The region of BBS7 not involved in the coiled-coil interaction (residues 364–376) is
shown in gray. C) two views of the BBS2-BBS7 coiled-coil interaction with the hydrophobic side chains at the interface shown
in yellow.
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Figure 4-5 Orientation of the BBS2-BBS7 coiled coil. A) Sequence alignment of BBS2, BBS7 and canonical heptad
repeat, together with the parallel and antiparallel template sequences. Residues are highlighted with yellow as
hydrophobic, blue as acidic, and red as basic. B) Foldit models for the coiledcoil based on the anti-parallel and
parallel templates. The Ca distances for each of the six crosslinks within the coiled-coil are listed below each model.
BBS7 residues 364-376 did not fit the coiled-coil template and were subsequently modeled as a random coil (Fig. 4).

Structural Model of the BBSome core complex
To obtain a structural model of the entire BBS2-7-9 complex, we combined the
BBS2/BBS7 coiled-coil model along with the domain models of the three BBS subunits and
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assembled them into the EM reconstruction using the 37 inter-domain crosslinks and the 22
inter-protein crosslinks identified by XL-MS. There were an additional five inter-domain
crosslinks that mapped to unstructured regions between the modeled domains. These crosslinks
could not be used for the integrated modeling. We employed the integrative modeling platform
(IMP) (28), which takes structural data from the crosslinks and the EM density and converts
them into spatial restraints that are combined into a scoring function to rank alternative models
(46). IMP iteratively searches the configurational space to generate structural models that satisfy
the spatial restraints, avoid steric clashes and retain sequence connectivity (46).
IMP iterations were run until the models converged to the point that they were producing
similar structures. From these, the top 500 scoring models were compared in a distance matrix
that calculates the root mean square deviation (RMSD) between the models (Figure 4-7A). The
matrix shows two clusters of models with related structures of 229 and 269 models each. Within
each cluster, IMP calculates the localization density from all the models, which gives the overall
shape of each protein in the complex. IMP also determines the global structural centroid for the
cluster and selects the individual model whose centroid is nearest to this global centroid. The
localization density and ribbon structure of the centroid model from cluster 1 is shown in Figure
6A. Though the two clusters both fit the crosslinking and EM data comparably well, the first
cluster satisfied more crosslinks than the second cluster, with 89.6 % and 85.4 % of crosslinks
satisfied, respectively (Figure 4-6B-C and Figure 4-7B). The localization density of model 1 also
fits the shape of the EM density well (Figure 4-6D). The main differences in conformation
between the
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Figure 4-6 Structural model of the BBS2-7-9 complex. A, three orthogonal views of the IMP localization densities
computed for each subunit. The ribbon structure of the centroid model is depicted. B, inter-domain and inter-protein
cross-links mapped onto the centroid model ribbon structure. Some domains are labeled to provide
landmarks. C, distributions of Euclidean Cα distances of the cross-linked lysines for each cross-linker. Blue
bars represent cross-links within the expected distance constraints and orange bars represent cross-links outside the
expected constraints (35 Å for DSS, 31 Å for DSG, and 33 Å for Leiker). D, the same views as in A docked in the EM
3D reconstruction of BBS2-7-9 complex. The reconstruction is depicted as a gray mesh surface.
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Figure 4-7 Precision of model clusters. A) Distance matrix of the RMSD between each of the top 500 scoring models. The
two main clusters are outlined with a dashed line. B) Precision statistics for each cluster. C) Localization densities and
centroid model ribbon structures for the two clusters. D) Root mean squared fluctuation (RMSF) heat map of the centroid
model ribbon of cluster 1. E) RMSF of each residue calculated for each subunit in cluster 1. Domain maps are shown below
for reference
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two clusters is that in cluster 1, the β-propellers of BBS2 and BBS7 point out toward the short
side of the EM density, whereas in cluster 2, they point out the long side. Otherwise, the interdomain contacts between subunits in each cluster of models are the same (Figure 4-7C).
An examination of the model structure shows BBS2 sitting between BBS7 and BBS9 and
making close contact with both subunits (Figure 4-6A). The coiled-coil is at the center of the
interaction between BBS2 and BBS7, but their GAE domains are also in close proximity. The αhelical domain of BBS2 wraps around to contact the α-helical domain of BBS9, forming the
primary point of contact between the two subunits. This proposed structure of the BBS2-7-9
complex is consistent with two previous studies showing binding of BBS2 to both BBS7 and
BBS9 and no interaction of BBS7 with BBS9 (23,27).

Effects of BBS-linked mutations
Multiple point mutations in BBS2, BBS7 and BBS9 have been linked to Bardet-Biedl
syndrome (30,43,47-54). To understand how these mutations might result in BBS, we measured
the effect of 14 of these mutations (7 in BBS2, 6 in BBS7 and 1 in BBS9) on the formation of the
BBS2-7-9 complex. We co-expressed BBS2, BBS7 and BBS9 in HEK-293T cells and measured
the interaction of BBS7 and BBS9 with BBS2 by co-immunoprecipitation. In the case of BBS7,
only the BBS2 L349W mutant showed a modest 30 % decrease in binding (Figure 4-8A). This
mutation is located in the BBS2/BBS7 coiled-coil (Figure 4-4) and may weaken the coiled-coil
interaction. In the case of BBS9, both the BBS2 R632P and the BBS9 G141R mutants showed a
marked 70% reduction in binding. The decrease observed in the BBS9 G141R mutant was a
result of lower cellular expression (Figure 4-8B). Quantification of the BBS9 bands from cell
lysates showed that expression of the G141R mutant was diminished by 76 % compared to the
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Figure 4-8 Effects of mutations on BBS2-7-9 complex assembly. A, the effects of BBS-linked mutations in BBS2, -7, and
-9 on BBS2-7-9 complex formation were measured. HEK-293T cells were co-transfected with c-Myc-tagged WT or
mutant BBS2, FLAG-tagged WT or mutant BBS7, and FLAG-tagged WT or mutant BBS9. BBS2 was immunoprecipitated,
and BBS2, -7, and -9 were detected by immunoblotting. The graph shows the quantification of the BBS7 and BBS9 bands
normalized to WT. Bars represent the average ± S.D. of three experiments for each mutant and six for WT. **, p < 0.01;
***, p < 0.001. Representative immunoblots from the BBS2 immunoprecipitates are shown below the graph. B,
expression levels of BBS2 L349W, R632P, and BBS9 G141R mutants in cell lysates were determined by immunoblotting.
Representative blots are shown and the graph gives the quantification of the BBS2, BBS7, and BBS9 bands normalized to
WT. Bars represent the average ± S.D. from six experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001. C, map of BBSlinked mutations on the BBS2-7-9 structural model. Locations of the mutations are shown with yellow dots. D, zoomed in
image shows the position of R632P in the α-helical domain of BBS2 and the cross-links (black lines) that confirm the
interaction of this region with BBS9.

expression of wild-type BBS9. In contrast, expression of the BBS2 R632P mutant showed a
slight 24 % decrease that was not statistically different from wild-type BBS2, indicating that the
mutation did not significantly impair the expression of BBS2, but that it disrupted the interaction
between BBS2 and BBS9. The position of the R632P mutation in the structural model suggests
how the mutation would disrupt the interaction between BBS2 and BBS9. The R632P mutation
is found within the α-helical domain of BBS2 and is in close proximity to α-helical domain of
BBS9 (Figure 4-5C-D). A proline substitution here would likely disrupt the formation of its helix
and perturb the structure in this region, thereby interfering with the interaction between BBS2
and BBS9.

Discussion
To perform its essential role in ciliary transport, the eight subunits of the BBSome must
be assembled into a functional complex. Our structural analysis of the BBS2-7-9 complex
provides mechanistic insight into how BBSome formation could occur. BBS2 and BBS7 form a
tight dimer principally via an extensive coiled-coil
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interaction involving residues 334-363 of BBS2 and residues 340-363 of BBS7. Previous studies
indicate that BBS2 and BBS7 are brought together by chaperones, including the chaperonin-like
BBS proteins (BBS6, BBS10 and BBS12) and the cytosolic chaperonin CCT (22,23). BBS9
associates with the BBS2/BBS7 dimer through an interaction with the α-helical domain of BBS2.
This interaction with BBS9 would link the BBS2/7 dimer to the hexameric BBS1,4,5,8,9,18
subcomplex (21). The hexameric subcomplex is stable and could be purified in milligram
quantities from insect cells (21), whereas the BBS2-7-9 complex is much less stable and we
could only purify microgram quantities from cultured human cells. These major differences in
stability suggest that the hexameric subcomplex forms first, followed by association of the
BBS2/7 dimer with the hexamer via interactions with BBS9. The instability of the BBS2/7 dimer
provides an explanation why chaperonin-like proteins are needed to bring the dimer together and
why mutations in the chaperonin-like proteins cause BBS.
In the BBS2-7-9 complex, the β-propeller domains of BBS2 and BBS7 are not involved
in interactions that hold the complex together, leaving them accessible for other interactions.
These domains might be sites of cargo binding in a manner analogous to the β-propellers of the α
and β´ subunits of the COPI complex, which forms membrane vesicle coats for retrograde
transport in the Golgi. These COPI β-propellers interact with membrane-associated cargos to
bring them into vesicles (55-57). Similarly, the accessible β-propeller domains of the BBS2-7-9
complex may associate with membrane proteins for transport in the primary cilium.
The BBS2-7-9 structure provides insight into the molecular basis of BBS disease caused
by the BBS2 R632P mutation. The interaction of this mutant with BBS9 is strongly inhibited,
while its binding to BBS7 is not. The reason for the disruption can be seen in the predicted
interaction surface between the α-helical domain of BBS2 with the α-helical domain of BBS9.
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Residues 628-635 of BBS2 are expected to form an α-helix that is located in the contact region
between BBS2 and BBS9 (Figure 4-8D). Three crosslinks between the α-helical domains of
BBS2 and BBS9 (K609-K687, K673-K687, K691-K821) position these two domains together in
the model and indicate that these domains closely interact (Figure 4-8D). The R632P mutation
would disrupt this helix of BBS2, which would in turn destabilize the interactions occurring at
this interface. Thus, the R632P mutation likely causes BBS because of an inability of the BBS2/7
dimer to bind to BBS9 and the rest of the BBSome.
Previous work has shown that the G141R mutation disrupts the folding of the BBS9 βpropeller and inhibits the expression of the mutant protein (43). G141 is found in the third βsheet of the BBS9 β-propeller, and the R mutations would be predicted to disrupt the β-sheet and
interfere with the folding of the β-propeller (43). We also see decreased expression of the BBS9
G141R mutant that results in decreased binding of BBS9 to BBS2. Without BBS9, the BBSome
cannot assemble and the disease ensues. The other mutants found in BBS2, 7 and 9 do not
disrupt formation of the BBS2-7-9 complex, suggesting that they might contribute to BBS in
some other way, perhaps by interfering with the association of the other BBSome proteins or
BBSome cargos.
When this work was submitted for review, a higher resolution structure of the intact
BBSome containing all eight subunits was published (58). A comparison of the two structural
models shows that the overall positions of BBS2, BBS7 and BBS9 are similar in the BBS2-7-9
subcomplex and the intact BBSome (Figure 9A). Both structures show the coiled-coil interaction
between BBS2 and BBS7 as well as the helical domain interaction between BBS2 and BBS9.The
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positions of the β-propeller domains differ between the two structures either because of the lower
resolution of the BBS2-7-9 subcomplex or because of differences resulting from

Figure 4-9 Comparison of the structural models of BBS2-7-9. A, the Cα models of BBS2, -7, and -9 from the
intact BBSome (58) and the BBS2-7-9 subcomplex (this study) are shown side by side for comparison. B, a
zoomed-in view of the helical bundle of BBS2 and BBS9 from the intact BBSome structure shows the position of
Arg632.
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interactions with in the intact BBSome. As an example of the later, the BBS9 β-propeller
extends away from the BBS2/7 dimer in the intact BBSome because of interactions with the
other BBSome subunits. Importantly, the intact BBSome structure shows clearly how the BBS2
R632P mutation could interfere with BBS2 binding to BBS9. In the intact structure, this residue
is located near a tight turn that links the two long antiparallel helices of the helical domain of
BBS2. These helices constitute the interface of the helical bundle formed between BBS2 and
BBS9 (Figure 4-9B). The helix breaking properties of the proline mutation would disrupt the end
of this helix as well as the turn, interfering with the antiparallel structure of these BBS2 helices
and inhibiting their ability to form the helical bundle with BBS9.
In summary, this analysis reveals the structural architecture of the BBS2-7-9 complex,
consisting of BBS2, BBS7 and BBS9, and identifies key interactions that bring the components
of this BBSome subcomplex together. Moreover, it provides a molecular basis for Bardet Biedl
syndrome caused by the BBS2 R632P mutation. These studies show how structural information
can inform our understanding of the BBSome and how its malfunction causes disease.

Methods
Purification of the BBSome 2-7-9 Subcomplex
Human embryonic kidney (HEK)-293T cells cultured in 1:1 Dulbecco Modified Eagle
media (DMEM) F12 with 10 % fetal bovine serum (FBS) in T-175 flasks were transfected at 80
% confluency with a transfection mixture consisting of purified plasmids of the pcS2+ vector
(Addgene) containing human BBS2 with protein C peptide (HPC4) and c-Myc tags at the Nterminus, a pcDNA3.1 vector (Thermo Fisher Scientific) containing human BBS7 with a Flag128

Strep tag at the N-terminus, a pcS2+ vector containing human BBS9 with a Flag tag at the Nterminus, and polyethylenimine (PEI). The DNA to PEI ratio was 1:3 by weight, and up to 90 μg
of DNA was used per T-175 flask. The media was replenished with DMEM/FBS after 2-4 hours,
and the cells were incubated for 48 additional hours before harvesting. Cells were lysed in 3 mL
of extraction buffer (20 mM HEPES pH 7.5, 20 mM NaCl, 1 % NP-40, 0.5 mM PMSF, and 6
µL/mL protease inhibitors cocktail (Sigma P8340), 24 U/mL benzonase nuclease) per gram of
cell pellet, and the lysate was cleared by centrifugation at 13,000 g for 15 minutes.
The BBS2-7-9 complex was purified at 4° C by affinity purification using 4 mL of StrepTactin resin (IBA Life Sciences) packed in a 2 cm diameter column and equilibrated with
equilibration buffer (20 mM HEPES pH 7.5 and 20 mM NaCl). The HEK-293T cell lysate was
loaded for 1 hour, washed with five column volumes of wash buffer (20 mM HEPES pH 7.5, 20
mM NaCl, and 0.05 % CHAPS), and then eluted with 2.5 column volumes of elution buffer (20
mM HEPES pH 7.5, 20 mM NaCl, 2.5 mM desthiobiotin, and 0.05 % CHAPS). The eluate was
concentrated to ~ 1 µg/µl using a 30 kDa cutoff filter (Millipore). The final protein concentration
was determined by comparing the absorbance at 280 nm to a 2 µg/µl bovine serum albumin
standard (Pierce) and correcting for minor buffer absorbance in a 2.5 µl nanodrop assay using a
BioTek synergy H4 plate reader. The concentrated sample was flash frozen in liquid nitrogen
and stored at 80oC. The purified core complex was analyzed by 10 % polyacrylamide SDS-gel
electrophoresis and its purity was determined to be 80-90 % by staining with Coomassie Brilliant
Blue (Thermo Fisher Scientific). The composition of the core complex was confirmed by
immunoblotting with anti-Flag and anti-c-Myc antibodies. Coomassie gels and immunoblots
were imaged using a LI-COR Odyssey infrared scanner.
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Some samples were further affinity purified using an HPC4 antibody-conjugated resin
(Roche), but yields from the HPC4 column were low, the improvements in purity were modest
and the crosslinks identified were very similar to the Strep-Tactin purified complex. Therefore,
we moved away from HPC4 purifications, but included crosslinking data from both purifications
in the structural analysis.

Crosslinking
The XL-MS analysis followed the protocol established by Leitner et al. (41).
Approximately 200 μg of the BBS2-7-9 complex at 1 µg/µl was crosslinked in 25 mM HEPES
pH 8.0, 100 mM KCl, and 325 μM of a 50 % mixture of H12/D12 disuccinimidyl suberate (DSS)
or H6/D6 disuccinimidyl glutarate (DSG) (Creative Molecules) at 37oC for half an hour. The
reaction was quenched by adding 50 mM ammonium bicarbonate to the crosslinked sample and
incubating at 37oC for 15 minutes. The sample was dried by a vacuum concentrator, denatured
in 100 mM Tris-HCl pH 8.5 and 8 M urea, reduced with 5 mM TCEP at 37° C for 30 minutes,
and alkylated with 10 mM iodoacetamide at room temperature in the dark for 30 minutes. The
sample was diluted with 150 mM ammonium bicarbonate to bring the urea concentration to 4 M,
and proteins were digested with 4 μg of lysyl endopeptidase (Wako Laboratories, cleaves at the
C-terminus of lysine) at a 1:50 enzyme to substrate ratio at 37oC for two hours. Subsequently,
urea was diluted to 1 M, and proteins were further digested with trypsin (Wako Laboratories,
cleaves at the C-terminus of lysine and arginine) at a 1:50 ratio at 37oC overnight. Peptide
fragments were purified on a C18 column (Waters), dried, and reconstituted in 35 μL size
exclusion chromatography (SEC) mobile phase (70:30:0.1 water:acetonitrile:TFA). Crosslinked
peptide fragments were enriched by SEC using a Superdex Peptide PC 3.2/30 column on an
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AKTA pure system (GE Healthcare) at a flow rate of 50 μL/min. Fractions from the leading half
of the elution peak were pooled, dried and resuspended in 2 % formic acid (41).
To increase the crosslink coverage, we also crosslinked with the Leiker trifunctional
crosslinking reagent (40). We adapted the previously published protocol by first adding 50 μg of
Leiker reagent to 200 μg of concentrated BBS2-7-9 complex in a final reaction volume of
approximately 200 μL. The reaction proceeded for an hour and was quenched with 10 μL of 550
mM ammonium bicarbonate for 20 min. The crosslinked complex was then concentrated on a
microcentrifuge filter (VWR 82031354) to < 20 μL and washed three times with 800 μL 8 M
Urea, 20 mM methylamine, 100 mM Tris-Base, pH 8.5, reconcentrating to < 20 μL with each
wash. The volume was brought up to 95 μL with the 8M urea solution, reduced with 5 mM
TCEP, alkylated with 10 mM iodoacetamide, and digested by lysyl endopeptidase and trypsin as
described above for the DSS and DSG crosslinking. The digested protein was then passed
through the microcentrifuge filter and incubated with 40 μL of Pierce™ High Capacity
Streptavidin Agarose (Thermo 20357) for two hours. The beads where then washed, the
crosslinked peptides were eluted and the samples were prepared for mass spectrometry as
described (40).

Mass spectrometry
The enriched DSS and DSG crosslinked peptide samples were separated using a Thermo
Fisher Scientific EASY-nLC 1000 liquid chromatograph system with a 15 cm Picofrit column
(New Objective) packed with Reprosil-Pur C18-AQ of 3 μm particle size, 120 Å pore size and
gradient of 5-95 % acetonitrile in 5 % DMSO and 0.1 % formic acid over 185 minutes and at a
flow rate of 350 nL/min. The column was coupled via electrospray to an Orbitrap Velos Pro
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mass spectrometer. The resolution of MS1 was 30,000 over a scan range of 380-2000 m/z.
Peptides with a charge state 3+ and greater were selected for HCD fragmentation at a normalized
collision energy of 35 % with 3 steps of 10 % (stepped NEC) and a resolution of 7,500. Dynamic
exclusion was enabled with a 10 ppm mass window and a one-minute time frame. Technical
duplicates were run for each of three different DSS preparations and two DSG preparations.
The Leiker crosslinked samples were separated by LC-MS using an Easy-nLC 1200
system (Thermo Fisher Scientific) with a 75 μm×2 cm pre-column (3 μm C18 Acclaim PepMap
100 #164946) and a 75 μm×25 cm analytical column (2 μm C18 3 μm C18, Acclaim PepMap
100 #164946), using a gradient of buffer A (0.1% formic acid) and buffer B (80 % acetonitrile
and 0.1 % formic acid) as follows: 0–6 % B for 2 min, 6–35 % B for 41 min, 35–100 % B for 10
min and 100 % B for 12 min at a flow rate of 300 nL/min. The column was coupled via
electrospray to an Orbitrap Fusion Lumos mass spectrometer run in data-dependent mode with
one scan at R = 60,000 (m/z = 350–2000), followed by ten HCD MS/MS microscans at R =
15,000 (first mass m/z = 110). The NCE was 27, with an isolation width of 2 m/z. The MS1 and
MS2 scan AGC targets were 4e5 and 1e5 and the maximum injection time was 60 ms for both
MS1 and MS2. Precursors of +1, +2, +7 or above, or unassigned charge states were rejected.
Exclusion of isotopes was disabled. Dynamic exclusion was 30 s.

XL-MS analysis
The xProphet (version 2.5.1)/xQuest (version 2.1.2) software pipeline (41) was used to
identify the DSS and DSG crosslinked peptides, the specific lysine residues involved in the
crosslink, and to evaluate the quality of each hit from the mass spectrometry data set. Tandem
mass spectra for parent ions with a mass shift of 12.075321 Da for the DSS crosslinker and
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6.04368 Da for the DSG crosslinker and a charge of +3 to +7 were classified as isotopic pairs
and evaluated in ion-tag mode with the following parameters: 2 missed cleavages, 5-50 amino
acid peptide length, carbamidomethyl fixed modification (57.02146 Da mass shift), oxidation
variable modification (15.99491 Da mass shift), 138.0680796 (DSS) and 96.02059 (DSG) Da
mass shift for intra- and inter-protein crosslinks, 156.0786442 (DSS) and 114.03115 (DSG) Da
for –OH monolinks, 155.0964278 and 113.04713 for –NH2 monolinks, MS1 tolerance of 10
ppm, and MS2 tolerance of 0.2 Da for common ions and 0.3 Da for crosslink ions.
The peptide sequence database was created by xQuest based on the amino acid sequence of
human BBS2, 7, and 9 (UniProt ID: Q9BXC9, Q8IW26, and Q3SYG4, respectively) and 9
common contaminant proteins (hHSPA1A, hHSPA1L, hHSPA8, hKRT1, hHSPA2, hTUBA1B,
hTUBA1C, hHSPA6, hTUBA3C, UniProt ID: P0DMV8, P34931, P11142, P04264, P54652,
P68363, Q9BQE3, P17066, P0DPH7, respectively). Spectra were searched against the database
which covered all possible crosslink combinations of the BBSome core proteins, and any spectra
that matched crosslinks in the database were counted and evaluated. Crosslink hits were screened
with the following xQuest criteria: 10 % false discovery rate, > 10 % total ion counts, -4 to 7
ppm MS1 tolerance window, > 20 xQuest Id-Score, and > 4 fragmentation events per peptide.
Any hit that met these parameters but scored below a decoy hit was not included in the crosslink
list unless it was found in another run (Table S2). Those xQuest hits that satisfied these
thresholds were inputted to the integrative modeling platform (IMP) for structural assessment
(28).
All spectra were also analyzed with the pLink2 software suite (version 2.3.5). The same
xQuest peptide sequence database was used and pLink added the sequences of other common
contaminant proteins. The program was then run using the preset DSS and Leiker_clv linker
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settings and custom DSG (LinkerComposition: C(5)H(4)O(2), MonoComposition
C(5)H(6)O(3)), DSG_heavy (C(5)H(-2)2H(6)O(2), C(5)2H(6)O(3)), and DSS_heavy (C(8)H(2)2H(12)O(2),C(5)2H(12)O(3)) linker profiles using the same crosslink and monolink masses as
described for xQuest. The spectra were then analyzed using conventional crosslinking (HCD)
conditions, with trypsin set as the protease and up to 3 missed cleavages allowed. Peptides were
selected with a mass between 600 and 6,000 Da and a length between 6 and 60 amino acids. The
precursor and fragment tolerances were ± 20 ppm. The peptides were searched using
carbamidomethyl C) fixed modifications and phospho Y, T, S and oxidized M variable
modifications. The results were filtered with a filter tolerance of ± 10 ppm and less than 5%
FDR. (Table S3)
The residue numbers given in the xQuest and pLink output included amino-terminal tag
lengths of 23 for BBS2, 16 for BBS7 and 11 for BBS9. These were subtracted to obtain the
correct residue number of the crosslinked amino acids. Unique crosslinks were then sorted into
intra-domain, intra-protein, and inter-protein data sets.

Mutagenesis
The consequences of 14 BBS-linked mutations in BBS2, 7 and 9 on the formation of
BBS2-7-9 were measured by co-immunoprecipitation. The mutations were introduced into Nterminally c-Myc-tagged BBS2 in pcS2+ vector, N-terminally Strep and Flag-tagged BBS7 in
pcDNA3.1 vector and N-terminally Flag-tagged BBS9 also in pcS2+ vector using mutagenic
PCR primers in a conventional PCR-based cloning protocol. All constructs were sequenced to
confirm that the mutations were correct. Constructs were transfected into HEK-293T cells grown
in 1:1 DMEM:F-12 media with 10 % FBS in 6-well plates at 80-90 % confluency using
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Lipofectamine 2000 according to the manufacturer’s protocol. Up to 3 μg of DNA was added to
each well, and the relative DNA amounts were 1:1:1 for the BBS2, 7 and 9 constructs. Cells
were fed with media three hours after transfection and incubated at 37° C for two days. Cells
were washed with a PBS solution (12 mM phosphate pH 7.4, 137 mM NaCl, 3 mM KCl) and
harvested in a PBS lysis buffer (PBS plus 6 uL/mL protease inhibitors cocktail (Sigma P8340),
0.6 mM PMSF, and 1 % NP-40) 48 hours after transfection. Lysed cells were triturated 8-10
times with a 25-gauge needle and syringe and cleared by centrifugation at 14,800 rpm in a
Sorvall Legend Micro 21 microfuge for 10 minutes. The lysates were immunoprecipitated by
incubating with an antibody to the c-Myc tag (Invitrogen 13-2500) on BBS2 as described above
and immunoblotted with the c-Myc antibody for BBS2 and with the anti-Flag antibody (Sigma
F3165) for BBS7 and BBS9 also as described above.

Protein separation for electron microscopy (EM)
The BBS2-7-9 sample from the Strep affinity purification was concentrated to 1 μg/μl,
and 150 μg of the sample was subjected to density gradient centrifugation to isolate the
complexes. The sample was loaded onto a 10-30 % glycerol gradient in a separation buffer (20
mM HEPES pH 7.5, 100 mM KCl, 4 mM CaCl2, 0.3 mM PMSF, 0.3 % protease inhibitor
cocktail, 3 mM DTT) and the ultracentrifugation was performed at 34,000 rpm in a SW55Ti
rotor at 4 °C for 16 hours. Fractions were collected from the top to the bottom, analyzed by 10 %
SDS-PAGE gels and silver stained. The fractions including pure BBS2-7-9 proteins were
selected for the electron microscopy analysis.
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EM grid preparation and data collection
Five µl aliquots of the protein samples were applied to 300 mesh grids (Maxtaform
Cu/Rh HR26) coated with a thin (~ 8 nm) carbon layer and glow-discharged for 15 seconds. The
grids were then stained (1 min) with 2 % uranyl acetate and air-dried before transmission EM
analysis. Images were taken using Tecnai F20 transmission EM electron microscope operating at
200 kV with a 4k FEI Eagle CCD camera. Images were recorded at a sampling rate of 1.78 Å/px.

Image processing and 3D reconstruction
Contrast transfer function was corrected using the CTFFIND3 program (59), which also
calculated potential astigmatism. Micrographs with visible drift and astigmatism were discarded.
8806 single particles of the BBSome core complex were selected manually, extracted from
micrographs, and normalized using the XMIPP software package (60). Two types of algorithms
were used to classify single images, CL2D (61) and Relion (62).
For 3D reconstruction, several initial models were tested in the first step of the 3D
reconstruction procedure using EMAN software (63): artificial noise, blob, and a model created
by a ‘common lines’ algorithm based on previously obtained 2D classes. Refinement was
performed until the 3D reconstructions from these initial models converged to stable, similar 3D
volumes. To obtain more structural detail, the 3D reconstruction from EMAN refinement was
subjected to projection matching using XMIPP. Resolution of the final 3D models was estimated
based on the FSC criterion (Fourier shell correlation) (64). The spatial frequency at 0.5
correlation was taken as the resolution of the model. Visualization of the 3D models was
performed using USCF Chimera (65).
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Structural modeling
All three BBS2-7-9 proteins share the same domain organization with N-terminal βpropeller, coiled-coil, γ-adaptin ear (GAE), platform, and C-terminal alpha-helical domains. The
secondary and tertiary structure of each domain was generated using the protein structure
prediction server I-TASSER (44), and the accuracy of these domain models was confirmed using
the intra-domain crosslinks from the XL-MS data. A crystal structure (PDB 4YD8) was used as a
domain model of the β-propeller of BBS9 (43).
Sequence analysis indicated a coiled-coil interaction between BBS2 residues 334-363
with BBS7 residues 339-376. To assess this possibility, we employed homology modeling using
the parallel coiled-coil from rat PAWR protein (chains A and B from PDB ID: 5fiy (66)) or the
anti-parallel coiled-coil from the hantavirus nucleocapsid protein (2ic9) as templates to obtain a
model structure for the BBS2/BBS7 coiled-coil. First, the coiled-coil heptad repeats were
identified in the BBS2 and BBS7 sequences, revealing three clear repeats in each sequence
(Figure 4-5A). Similarly, three coiled-coil heptad repeats with ideal coiled-coil geometry were
identified in the models and used as template structures. The program Foldit (45) was used to
thread the BBS2 and BBS7 sequences into the templates. The triple heptad repeats of BBS2 and
BBS7 were aligned with the heptad repeats of the templates and placed fully opposite and in
register with one another. Foldit was then used to sample all side chain and backbone degrees of
freedom in the resulting BBS2/BBS7 homology models. Restraints of 11.5 Å for DSS and 7.4 Å
for DSG were applied between Nζ atoms of the crosslinked lysine residues identified by XL-MS.
With these restraints applied, the models were again allowed to sample all side chain and
backbone degrees of freedom. The region of the homology model comprising BBS7 residues
364-376 did not fit the restraints well and so Foldit was used to unfold this region and refolded it
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using the aforementioned restraints. The result was an unstructured random coil for BBS7
residues 364-376 positioned outside the high confidence coiled-coil model for the rest of the
structure.
The Integrative Modeling Platform (IMP) version 2.8.0 (67) was used to predict how the
individual BBSome core complex domains are oriented relative to each other. The domain
models described previously were treated as rigid bodies. The parallel coiled-coil interaction of
BBS2 and BBS7 was treated as a single rigid body without the unstructured residues (364-376)
of BBS7. Linker regions between domains were approximated as 20 residue beads. Each of the
three subunits was treated as super rigid bodies. Model restraints were generated from the
crosslink data and from the EM reconstruction electron density. A weight of 120 was applied to
the EM restraint. 3,200,000 models were generated in runs of 100,000 frames. The top 500
scoring models were then divided into two clusters and localization densities for each subunit
were calculated for each cluster. Cluster precision was then gauged by calculating the root mean
square fluctuation between models in the cluster and for each residue in each subunit (Figure
4-7D-E). Model accuracy was determined by using the PDB file of the centroid model for all
three subunits to calculate crosslink distances and to determine the fit within the EM density
envelope.

Experimental Design and Statistical Rationale
Three separate purifications of the BBS2-7-9 complex were crosslinked with DSS, two
were crosslinked with DSG and four were crosslinked with Leiker reagent. All crosslinks that
met the identification requirements were included in the IMP data. Binding experiments to
measure the effects of BBS-linked mutations on BBS2-7-9 interactions were repeated three times
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in biologically independent assays to determine if differences from WT controls were significant.
P-values were calculated using a 2-tailed T-test assuming a normal distribution.
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Chapter 5 : Conclusion

At the onset of these investigations, we posed several questions. Do β-propellers follow a
conserved folding trajectory, or are they each unique? How does the CCT nucleotide cycle
interact with β-propeller folding? How does CCT closure behave under physiological
conditions? Do the subunits close cooperatively? Is there a sequence to closure? Can substrate
remains bound as the folding chamber closes?
We observed that each of the β-propellers we studied had a unique folding trajectory. The
structures we determined for these β-propellers match their unique folding trajectories. For
example, BBS7 relies on the BBS chaperonin-like complex for folding [1]. Gβ1 binds the apical
domains of CCT at the rim of the folding chamber with PhLP1 bridging across the CCT folding
cavity and making contact with Gβ1 [2]. In contrast, Gβ5 binds between rings with PhLP1
reaching down from rim of CCT, while mLST8 binds between rings and does not need PhLP1
for folding [3]. Intriguingly, each β-propeller we studied was bound on the slow ATP
hydrolyzing side of the CCT folding cavity [2, 3]. This observation supports the power stroke
hypothesis that substrates begin on the fast hydrolyzing side of CCT and are passed to and
sequestered on the slow hydrolyzing side until they are released [4].
Furthermore, we observed that in the absence of nucleotide, CCT subunits can still open
and close in an uncoordinated manner and with substrate still bound. Previous work has
indicated that CCT closes in a coordinated, sequential manner in the presence of ATP [5, 6].
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However, our data indicate that concerted closure is dependent on the presence of nucleotide and
not on the conformational changes of the individual subunits, per se.
Lastly, interactions between CCT and PhLP1 induce conformational changes in CCT that
could modulate CCT activity. We present the first substrate-CCT structure at high enough
resolution to observe the structural changes induced by a CCT binding partner. Members of the
phosducin-like protein family have been shown to decrease the rate of ATP hydrolysis by CCT
[7] and our structure gives insight into the potential mechanism of this phenomenon. We
observed that PhLP1 induces conformational changes in CCT6, a CCT subunit that does not
exchange ADP for ATP [3, 8]. This PhLP1-induced conformational change interrupts the
network of inter subunit contacts, most notably the interaction between the CCT6 lid segment
and the CCT8 release loop of substrate (RLS) region.
Collectively, these observations allow for new predictions and hypotheses. For example,
the data allows us to predict how other β-propellers will bind CCT. Gβ2-4 will likely bind like
Gβ1 at the rim of the CCT folding chamber because they all depend on PhLP1 for release from
CCT [9, 10]. Substrates that do not require PhLP1 for folding, such as mLST8, are more readily
released from CCT by ATP hydrolysis [3].
Here, we have presented a general model of β-propeller folding: β-propellers are held
between the rings until folding is complete and/or downstream binding partners become
available. The largest differences in folding trajectory are largely mediated by interactions with
downstream binding partners, such as PhLP1, mTOR, or RGS proteins.
Several questions still remain and the discoveries outlined here open up several new avenues
of inquiry. Our structures were extracted from cells in the absence of ATP and purified in a
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procedure that required several hours, thus we do not know the process of b-propeller protein
folding prior to imaging on the microscope. To gain a complete understanding of the CCT
folding mechanism, a series of structures of CCT folding a β-propeller at different stages of the
folding process will be necessary. First will be to purify and image CCT binding cotranslationally with the ribosome. This will reveal if the β-propeller goes directly in between the
rings upon translation or if it first interacts with CCT at another location. Next will be to image
CCT folding a substrate out of denaturant in the absence of any nucleotide. This will indicate if
ATP hydrolysis is necessary to push the β-propeller in between the rings. A highly informative
structure will be to close the CCT cavity with the ATP transition sate analog ADP-AlFx and see
where the substrate binds CCT. Closing the folding cavity should also greatly improve the
resolution of the β-propeller substrate and possibly PhLP1. At this resolution, we should be able
to directly observe to what extent the β-propeller is folded. It will also be interesting to test if
forming a chimeric protein with the Gβ1 N-terminal α-helix is sufficient to alter where a βpropeller binds to CCT.
Altogether, this work provides a solid basis upon which build our understanding of βpropeller folding and CCT function in general. As imaging and image processing capabilities
continue to improve, we will gain further atomic level insight into how CCT assists its substrates
to transition from disorder to native folds.
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